The Rotterdam Study: 2018 update on objectives, design and main results

1.

Oeppen J, Vaupel JW. Demography. Broken limits to life expectancy. Science. 2002;296(5570):1029–31.PubMedCrossRef

2.

Peto R, Doll R. There is no such thing as aging. BMJ. 1997;315(7115):1030–2.PubMedCrossRefPubMedCentral

3.

Hofman A, Grobbee DE, de Jong PT, van den Ouweland FA. Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. Eur J Epidemiol. 1991;7(4):403–22.PubMedCrossRef

4.

Hofman A, Breteler MM, van Duijn CM, Krestin GP, Pols HA, Stricker BH, et al. The Rotterdam Study: objectives and design update. Eur J Epidemiol. 2007;22(11):819–29.PubMedCrossRefPubMedCentral

5.

Hofman A, van Duijn CM, Franco OH, Ikram MA, Janssen HL, Klaver CC, et al. The Rotterdam Study: 2012 objectives and design update. Eur J Epidemiol. 2011;26(8):657–86.PubMedCrossRefPubMedCentral

6.

Hofman A, Brusselle GG, Darwish Murad S, van Duijn CM, Franco OH, Goedegebure A, et al. The Rotterdam Study: 2016 objectives and design update. Eur J Epidemiol. 2015;30(8):661–708.PubMedCrossRefPubMedCentral

7.

Adami HO, Nyren O. Enigmas, priorities and opportunities in cancer epidemiology. Eur J Epidemiol. 2016;31(12):1161–71.PubMedCrossRef

8.

Kooijman MN, Kruithof CJ, van Duijn CM, Duijts L, Franco OH, van IJzendoorn MH, et al. The Generation R Study: design and cohort update 2017. Eur J Epidemiol. 2016;31(12):1243–64.PubMedCrossRef

9.

Kuh D. From paediatrics to geriatrics: a life course perspective on the MRC National Survey of Health and Development. Eur J Epidemiol. 2016;31(11):1069–79.PubMedCrossRefPubMedCentral

10.

Kuh D, Wong A, Shah I, Moore A, Popham M, Curran P, et al. The MRC National Survey of Health and Development reaches age 70: maintaining participation at older ages in a birth cohort study. Eur J Epidemiol. 2016;31(11):1135–47.PubMedCrossRefPubMedCentral

11.

Kuller LH. The limitations of opportunistic epidemiology, pseudopod epidemiology. Eur J Epidemiol. 2016;31(10):957–66.PubMedCrossRef

12.

Hoogendijk EO, Deeg DJH, Poppelaars J, van der Horst M, van Groenou MIB, Comijs HC, et al. The Longitudinal Aging Study Amsterdam: cohort update 2016 and major findings. Eur J Epidemiol. 2016;31(9):927–45.PubMedCrossRefPubMedCentral

13.

Mohner M. The hidden impact of a healthy-worker effect on the results of the Diesel Exhaust in Miners Study. Eur J Epidemiol. 2016;31(8):803–4.PubMedCrossRefPubMedCentral

14.

Porta M, Bolumar F. Caution: work in progress While the methodological “revolution’’ deserves in-depth study, clinical researchers and senior epidemiologists should not be disenfranchised. Eur J Epidemiol. 2016;31(6):535–9.PubMedCrossRef

15.

Rothman KJ. Disengaging from statistical significance. Eur J Epidemiol. 2016;31(5):443–4.PubMedCrossRef

16.

Greenland S, Senn SJ, Rothman KJ, Carlin JB, Poole C, Goodman SN, et al. Statistical tests, P values, confidence intervals, and power: a guide to misinterpretations. Eur J Epidemiol. 2016;31(4):337–50.PubMedCrossRefPubMedCentral

17.

Ludvigsson JF, Almqvist C, Bonamy AKE, Ljung R, Michaelsson K, Neovius M, et al. Registers of the Swedish total population and their use in medical research. Eur J Epidemiol. 2016;31(2):125–36.PubMedCrossRef

18.

Cox DR. The design of empirical studies: towards a unified view. Eur J Epidemiol. 2016;31(3):217–28.PubMedCrossRef

19.

Ikram MA, van der Lugt A, Niessen WJ, Koudstaal PJ, Krestin GP, Hofman A, et al. The Rotterdam Scan Study: design update 2016 and main findings. Eur J Epidemiol. 2015;30(12):1299–315.PubMedCrossRefPubMedCentral

20.

Zins M, Goldberg M, Team C. The French CONSTANCES population-based cohort: design, inclusion and follow-up. Eur J Epidemiol. 2015;30(12):1317–28.PubMedCrossRefPubMedCentral

21.

Ikram MA. Molecular pathological epidemiology: the role of epidemiology in the omics-era. Eur J Epidemiol. 2015;30(10):1077–8.PubMedCrossRefPubMedCentral

22.

Greenland S, Mansournia MA. Limitations of individual causal models, causal graphs, and ignorability assumptions, as illustrated by random confounding and design unfaithfulness. Eur J Epidemiol. 2015;30(10):1101–10.PubMedCrossRef

23.

Nishihara R, VanderWeele TJ, Shibuya K, Mittleman MA, Wang ML, Field AE, et al. Molecular pathological epidemiology gives clues to paradoxical findings. Eur J Epidemiol. 2015;30(10):1129–35.PubMedCrossRefPubMedCentral

24.

Lai HTM, Threapleton DE, Day AJ, Williamson G, Cade JE, Burley VJ. Fruit intake and cardiovascular disease mortality in the UK Women’s Cohort Study. Eur J Epidemiol. 2015;30(9):1035–48.PubMedCrossRef

25.

Dhana K, Kavousi M, Ikram MA, Tiemeier H, Hofman A, Franco OH. Body shape index in comparison with other anthropometric measures in prediction of total and cause-specific mortality. J Epidemiol Community Health 2016;70(1):90–6.PubMedCrossRef

26.

Dhana K, Koolhas C, Schoufour J, Rivadeneira F, Hofman A, Kavousi M, et al. Association of anthropometric measures with fat and fat-free mass in the elderly: the Rotterdam Study. Maturitas. 2016;88:96–100.PubMedCrossRef

27.

Dhana K, van Rosmalen J, Vistisen D, Ikram MA, Hofman A, Franco OH, et al. Trajectories of body mass index before the diagnosis of cardiovascular disease: a latent class trajectory analysis. Eur J Epidemiol. 2016;31(6):583–92.PubMedCrossRefPubMedCentral

28.

Dhana K, Berghout MA, Peeters A, Ikram MA, Tiemeier H, Hofman A, et al. Obesity in older adults and life expectancy with and without cardiovascular disease. Int J Obes (Lond). 2016;40(10):1535–40.CrossRef

29.

Hagg S, Fall T, Ploner A, Magi R, Fischer K, Draisma HH, et al. Adiposity as a cause of cardiovascular disease: a Mendelian randomization study. Int J Epidemiol. 2015;44(2):578–86.PubMedCrossRefPubMedCentral

30.

Fall T, Hagg S, Ploner A, Magi R, Fischer K, Draisma HH, et al. Age- and sex-specific causal effects of adiposity on cardiovascular risk factors. Diabetes. 2015;64(5):1841–52.PubMedCrossRefPubMedCentral

31.

Kavousi M, Leening MJ, Nanchen D, Greenland P, Graham IM, Steyerberg EW, et al. Comparison of application of the ACC/AHA guidelines, adult treatment panel III guidelines, and European Society of Cardiology guidelines for cardiovascular disease prevention in a European cohort. JAMA. 2014;311(14):1416–23.PubMedCrossRef

32.

van Dijk GM, Kavousi M, Troup J, Franco OH. Health issues for menopausal women: the top 11 conditions have common solutions. Maturitas. 2015;80(1):24–30.PubMedCrossRef

33.

Jaspers L, Daan NM, van Dijk GM, Gazibara T, Muka T, Wen KX, et al. Health in middle-aged and elderly women: a conceptual framework for healthy menopause. Maturitas. 2015;81(1):93–8.PubMedCrossRef

34.

Leening MJ, Ferket BS, Steyerberg EW, Kavousi M, Deckers JW, Nieboer D, et al. Sex differences in lifetime risk and first manifestation of cardiovascular disease: prospective population based cohort study. BMJ. 2014;349:g5992.PubMedCrossRefPubMedCentral

35.

Jaspers L, Schoufour JD, Erler NS, Darweesh SK, Portegies ML, Sedaghat S, et al. Development of a healthy aging score in the population-based Rotterdam Study: evaluating age and sex differences. J Am Med Dir Assoc. 2017;18(3):276 e1–7.CrossRef

36.

Jaspers L, Kavousi M, Erler NS, Hofman A, Laven JSE, Franco OH. Fertile lifespan characteristics and all-cause and cause-specific mortality among postmenopausal women: the Rotterdam Study. Fertil Steril. 2017;107(2):448–56.PubMedCrossRef

37.

Jaspers L, Dhana K, Muka T, Meun C, Kiefte-de Jong JC, Hofman A, et al. Sex steroids, sex hormone-binding globulin and cardiovascular health in men and postmenopausal women: the Rotterdam Study. J Clin Endocrinol Metab. 2016;101(7):2844–52.PubMedCrossRef

38.

Daan NMP, Jaspers L, Koster MPH, Broekmans FJM, de Rijke YB, Franco OH, et al. Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features. Hum Reprod. 2015;30(10):2376–86.PubMedCrossRef

39.

Daan NMP, Muka T, Koster MPH, van Lennep JER, Lambalk CB, Laven JSE, et al. Cardiovascular risk in women with premature ovarian insufficiency compared to premenopausal women at middle age. J Clin Endocrinol Metab. 2016;101(9):3306–15.PubMedCrossRef

40.

Bleumink GS, Knetsch AM, Sturkenboom MC, Straus SM, Hofman A, Deckers JW, et al. Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure The Rotterdam Study. Eur Heart J. 2004;25(18):1614–9.PubMedCrossRef

41.

Heeringa J, van der Kuip DA, Hofman A, Kors JA, van Herpen G, Stricker BH, et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J. 2006;27(8):949–53.PubMedCrossRef

42.

Krijthe BP, Kunst A, Benjamin EJ, Lip GY, Franco OH, Hofman A, et al. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. Eur Heart J. 2013;34(35):2746–51.PubMedCrossRefPubMedCentral

43.

Nanchen D, Leening MJ, Locatelli I, Cornuz J, Kors JA, Heeringa J, et al. Resting heart rate and the risk of heart failure in healthy adults: the Rotterdam Study. Circ Heart Fail. 2013;6(3):403–10.PubMedCrossRef

44.

van Vark LC, Kardys I, Bleumink GS, Knetsch AM, Deckers JW, Hofman A, et al. Lipoprotein-associated phospholipase A2 activity and risk of heart failure: the Rotterdam study. Eur Heart J. 2006;27(19):2346–52.PubMedCrossRef

45.

Heeringa J, van der Kuip DA, Hofman A, Kors JA, van Rooij FJ, Lip GY, et al. Subclinical atherosclerosis and risk of atrial fibrillation: the Rotterdam Study. Arch Intern Med. 2007;167(4):382–7.PubMedCrossRef

46.

Heeringa J, Hoogendoorn EH, van der Deure WM, Hofman A, Peeters RP, Hop WC, et al. High-normal thyroid function and risk of atrial fibrillation: the Rotterdam Study. Arch Intern Med. 2008;168(20):2219–24.PubMedCrossRef

47.

Krijthe BP, de Jong FH, Hofman A, Franco OH, Witteman JC, Stricker BH, et al. Dehydroepiandrosterone sulfate levels and risk of atrial fibrillation: the Rotterdam Study. Eur J Prev Cardiol. 2014;21(3):291–8.PubMedCrossRef

48.

Bos D, Vernooij MW, Shahzad R, Kavousi M, Hofman A, van Walsum T, et al. Epicardial fat volume and the risk of atrial fibrillation in the general population free of cardiovascular disease. JACC Cardiovasc Imaging 2017. doi:10.1016/j.jcmg.2016.12.005.PubMed

49.

Alonso A, Krijthe BP, Aspelund T, Stepas KA, Pencina MJ, Moser CB, et al. Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium. J Am Heart Assoc. 2013;2(2):e000102.PubMedCrossRefPubMedCentral

50.

Vasan RS, Glazer NL, Felix JF, Lieb W, Wild PS, Felix SB, et al. Genetic variants associated with cardiac structure and function: a meta-analysis and replication of genome-wide association data. JAMA. 2009;302(2):168–78.PubMedCrossRefPubMedCentral

51.

Pfeufer A, van Noord C, Marciante KD, Arking DE, Larson MG, Smith AV, et al. Genome-wide association study of PR interval. Nat Genet. 2010;42(2):153–9.PubMedCrossRefPubMedCentral

52.

den Hoed M, Eijgelsheim M, Esko T, Brundel BJ, Peal DS, Evans DM, et al. Identification of heart rate-associated loci and their effects on cardiac conduction and rhythm disorders. Nat Genet. 2013;45(6):621–31.CrossRef

53.

Benjamin EJ, Rice KM, Arking DE, Pfeufer A, van Noord C, Smith AV, et al. Variants in ZFHX3 are associated with atrial fibrillation in individuals of European ancestry. Nat Genet. 2009;41(8):879–81.PubMedCrossRefPubMedCentral

54.

Ellinor PT, Lunetta KL, Albert CM, Glazer NL, Ritchie MD, Smith AV, et al. Meta-analysis identifies six new susceptibility loci for atrial fibrillation. Nat Genet. 2012;44(6):670–5.PubMedCrossRefPubMedCentral

55.

Ligthart S, van Herpt TT, Leening MJ, Kavousi M, Hofman A, Stricker BH, et al. Lifetime risk of developing impaired glucose metabolism and eventual progression from prediabetes to type 2 diabetes: a prospective cohort study. Lancet Diabetes Endocrinol. 2016;4(1):44–51.PubMedCrossRef

56.

Dhana K, Berghout MA, Peeters A, Ikram MA, Tiemeier H, Hofman A, et al. Obesity in older adults and life expectancy with and without cardiovascular disease. Int J Obes. 2016;40(10):1535–40.CrossRef

57.

Muka T, Nano J, Jaspers L, Meun C, Bramer WM, Hofman A, et al. Associations of steroid sex hormones and sex hormone-binding globulin with the risk of type 2 diabetes in women: a population-based cohort study and meta-analysis. Diabetes. 2017;66(3):577–86.PubMedCrossRef

58.

Brahimaj A, Ligthart S, Ghanbari M, Ikram MA, Hofman A, Franco OH, et al. Novel inflammatory markers for incident pre-diabetes and type 2 diabetes: the Rotterdam Study. Eur J Epidemiol. 2017;32(3):217–26.PubMedCrossRefPubMedCentral

59.

Brahimaj A, Ligthart S, Ikram MA, Hofman A, Franco OH, Sijbrands EJ, et al. Serum levels of apolipoproteins and incident type 2 diabetes: a prospective cohort study. Diabetes Care. 2017;40(3):346–51.PubMedCrossRef

60.

de Vries PS, van Herpt TT, Ligthart S, Hofman A, Ikram MA, van Hoek M, et al. ADAMTS13 activity as a novel risk factor for incident type 2 diabetes mellitus: a population-based cohort study. Diabetologia. 2017;60(2):280–6.PubMedCrossRef

61.

Brahimaj A, Muka T, Kavousi M, Laven JS, Dehghan A, Franco OH. Serum dehydroepiandrosterone levels are associated with lower risk of type 2 diabetes: the Rotterdam Study. Diabetologia. 2017;60(1):98–106.PubMedCrossRef

62.

Ligthart S, Steenaard RV, Peters MJ, van Meurs JB, Sijbrands EJ, Uitterlinden AG, et al. Tobacco smoking is associated with DNA methylation of diabetes susceptibility genes. Diabetologia. 2016;59(5):998–1006.PubMedCrossRefPubMedCentral

63.

Hak AE, Pols HA, Visser TJ, Drexhage HA, Hofman A, Witteman JC. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med. 2000;132(4):270–8.PubMedCrossRef

64.

Kavousi M, Elias-Smale S, Rutten JH, Leening MJ, Vliegenthart R, Verwoert GC, et al. Evaluation of newer risk markers for coronary heart disease risk classification: a cohort study. Ann Intern Med. 2012;156(6):438–44.PubMedCrossRef

65.

Rutten JH, Mattace-Raso FU, Steyerberg EW, Lindemans J, Hofman A, Wieberdink RG, et al. Amino-terminal pro-B-type natriuretic peptide improves cardiovascular and cerebrovascular risk prediction in the population: the Rotterdam study. Hypertension. 2010;55(3):785–91.PubMedCrossRef

66.

Kardys I, de Maat MP, Uitterlinden AG, Hofman A, Witteman JC. C-reactive protein gene haplotypes and risk of coronary heart disease: the Rotterdam Study. Eur Heart J. 2006;27(11):1331–7.PubMedCrossRef

67.

Oei HH, van der Meer IM, Hofman A, Koudstaal PJ, Stijnen T, Breteler MM, et al. Lipoprotein-associated phospholipase A2 activity is associated with risk of coronary heart disease and ischemic stroke: the Rotterdam Study. Circulation. 2005;111(5):570–5.PubMedCrossRef

68.

van der Bom JG, de Knijff P, Haverkate F, Bots ML, Meijer P, de Jong PT, et al. Tissue plasminogen activator and risk of myocardial infarction. The Rotterdam Study. Circulation. 1997;95(12):2623–7.PubMedCrossRef

69.

Ligthart S, Sedaghat S, Ikram MA, Hofman A, Franco OH, Dehghan A. EN-RAGE: a novel inflammatory marker for incident coronary heart disease. Arterioscler Thromb Vasc Biol. 2014;34(12):2695–9.PubMedCrossRef

70.

Sonneveld MA, Kavousi M, Ikram MA, Hofman A, Rueda Ochoa OL, Turecek PL, et al. Low ADAMTS-13 activity and the risk of coronary heart disease—a prospective cohort study: the Rotterdam Study. J Thromb Haemost. 2016;14(11):2114–20.PubMedCrossRef

71.

Sonneveld MAH, de Maat MPM, Portegies MLP, Kavousi M, Hofman A, Turecek PL, et al. Low ADAMTS13 activity is associated with an increased risk of ischemic stroke. Blood. 2015;126(25):2739–46.PubMedCrossRef

72.

Sonneveld MAH, Franco OH, Ikram MA, Hofman A, Kavousi M, de Maat MPM, et al. Von Willebrand factor, ADAMTS13, and the risk of mortality the Rotterdam Study. Arterioscler Thromb Vasc. 2016;36(12):2446–51.CrossRef

73.

Koller MT, Leening MJ, Wolbers M, Steyerberg EW, Hunink MG, Schoop R, et al. Development and validation of a coronary risk prediction model for older U.S. and European persons in the Cardiovascular Health Study and the Rotterdam Study. Ann Intern Med. 2012;157(6):389–97.PubMedCrossRefPubMedCentral

74.

Dhana K, Ikram MA, Hofman A, Franco OH, Kavousi M. Anthropometric measures in cardiovascular disease prediction: comparison of laboratory-based versus non-laboratory-based model. Heart. 2015;101(5):377–83.PubMedCrossRef

75.

Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation. 1997;96(5):1432–7.PubMedCrossRef

76.

Mattace-Raso FU, van der Cammen TJ, Hofman A, van Popele NM, Bos ML, Schalekamp MA, et al. Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation. 2006;113(5):657–63.PubMedCrossRef

77.

Vliegenthart R, Oudkerk M, Hofman A, Oei HH, van Dijck W, van Rooij FJ, et al. Coronary calcification improves cardiovascular risk prediction in the elderly. Circulation. 2005;112(4):572–7.PubMedCrossRef

78.

van der Meer IM, Bots ML, Hofman A, del Sol AI, van der Kuip DA, Witteman JC. Predictive value of noninvasive measures of atherosclerosis for incident myocardial infarction: the Rotterdam Study. Circulation. 2004;109(9):1089–94.PubMedCrossRef

79.

van Sloten TT, Sedaghat S, Laurent S, London GM, Pannier B, Ikram MA, et al. Carotid stiffness is associated with incident stroke a systematic review and individual participant data meta-analysis. J Am Coll Cardiol. 2015;66(19):2116–25.PubMedCrossRef

80.

Elias-Smale SE, Proenca RV, Koller MT, Kavousi M, van Rooij FJ, Hunink MG, et al. Coronary calcium score improves classification of coronary heart disease risk in the elderly: the Rotterdam study. J Am Coll Cardiol. 2010;56(17):1407–14.PubMedCrossRef

81.

Kavousi M, Leening MJ, Witteman JC. Markers for prediction of cardiovascular disease risk. JAMA. 2012;308(24):2561 (author reply-2).PubMedCrossRef

82.

Elias-Smale SE, Wieberdink RG, Odink AE, Hofman A, Hunink MG, Koudstaal PJ, et al. Burden of atherosclerosis improves the prediction of coronary heart disease but not cerebrovascular events: the Rotterdam Study. Eur Heart J. 2011;32(16):2050–8.PubMedCrossRef

83.

Leening MJ, Elias-Smale SE, Kavousi M, Felix JF, Deckers JW, Vliegenthart R, et al. Coronary calcification and the risk of heart failure in the elderly: the Rotterdam Study. JACC Cardiovasc Imaging. 2012;5(9):874–80.PubMedCrossRef

84.

Kavousi M, Desai CS, Ayers C, Blumenthal RS, Budoff MJ, Mahabadi AA, et al. Prevalence and prognostic implications of coronary artery calcification in low-risk women a meta-analysis. Jama J Am Med Assoc. 2016;316(20):2126–34.CrossRef

85.

Kardys I, Klaver CC, Despriet DD, Bergen AA, Uitterlinden AG, Hofman A, et al. A common polymorphism in the complement factor H gene is associated with increased risk of myocardial infarction: the Rotterdam Study. J Am Coll Cardiol. 2006;47(8):1568–75.PubMedCrossRef

86.

Psaty BM, Hofman A. Genome-wide association studies and large-scale collaborations in epidemiology. Eur J Epidemiol. 2010;25(8):525–9.PubMedCrossRef

87.

Psaty BM, O’Donnell CJ, Gudnason V, Lunetta KL, Folsom AR, Rotter JI, et al. Cohorts for heart and aging research in genomic epidemiology (CHARGE) consortium: design of prospective meta-analyses of genome-wide association studies from 5 cohorts. Circ Cardiovasc Genet. 2009;2(1):73–80.PubMedCrossRefPubMedCentral

88.

Dehghan A, Kottgen A, Yang Q, Hwang SJ, Kao WL, Rivadeneira F, et al. Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study. Lancet. 2008;372(9654):1953–61.PubMedCrossRefPubMedCentral

89.

Yu B, Li AH, Muzny D, Veeraraghavan N, de Vries PS, Bis JC, et al. Association of rare loss-of-function alleles in HAL, serum histidine: levels and incident coronary heart disease. Circ Cardiovasc Genet. 2015;8(2):351–5.PubMedCrossRefPubMedCentral

90.

Kottgen A, Glazer NL, Dehghan A, Hwang SJ, Katz R, Li M, et al. Multiple loci associated with indices of renal function and chronic kidney disease. Nat Genet. 2009;41(6):712–7.PubMedCrossRefPubMedCentral

91.

International Consortium for Blood Pressure Genome-Wide Association S, Ehret GB, Munroe PB, Rice KM, Bochud M, Johnson AD, et al. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature. 2011;478(7367):103–9.CrossRef

92.

Levy D, Ehret GB, Rice K, Verwoert GC, Launer LJ, Dehghan A, et al. Genome-wide association study of blood pressure and hypertension. Nat Genet. 2009;41(6):677–87.PubMedCrossRefPubMedCentral

93.

Wain LV, Verwoert GC, O’Reilly PF, Shi G, Johnson T, Johnson AD, et al. Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure. Nat Genet. 2011;43(10):1005–11.PubMedCrossRefPubMedCentral

94.

Ganesh SK, Zakai NA, van Rooij FJ, Soranzo N, Smith AV, Nalls MA, et al. Multiple loci influence erythrocyte phenotypes in the CHARGE Consortium. Nat Genet. 2009;41(11):1191–8.PubMedCrossRefPubMedCentral

95.

Dehghan A, Dupuis J, Barbalic M, Bis JC, Eiriksdottir G, Lu C, et al. Meta-analysis of genome-wide association studies in > 80 000 subjects identifies multiple loci for C-reactive protein levels. Circulation. 2011;123(7):731–8.PubMedCrossRefPubMedCentral

96.

Smith JG, Platonov PG, Hedblad B, Engstrom G, Melander O. Atrial fibrillation in the Malmo diet and cancer study: a study of occurrence, risk factors and diagnostic validity. Eur J Epidemiol [Article]. 2010;25(2):95–102.CrossRef

97.

Huffman J, de Vries P, Morrison A, Sabater-Lleal M, Kacprowski T, Auer P, et al. Rare and low-frequency variants and their association with plasma levels of fibrinogen, FVII, FVIII, and vWF. Blood 2015;126(11):e19–29.PubMedCrossRefPubMedCentral

98.

de Vries PS, Boender J, Sonneveld MA, Rivadeneira F, Ikram MA, Rottensteiner H, et al. Genetic variants in the ADAMTS13 and SUPT3H genes are associated with ADAMTS13 activity. Blood. 2015;125(25):3949–55.PubMedCrossRef

99.

Bis JC, Kavousi M, Franceschini N, Isaacs A, Abecasis GR, Schminke U, et al. Meta-analysis of genome-wide association studies from the CHARGE consortium identifies common variants associated with carotid intima media thickness and plaque. Nat Genet. 2011;43(10):940–7.PubMedCrossRefPubMedCentral

100.

Murabito JM, White CC, Kavousi M, Sun YV, Feitosa MF, Nambi V, et al. Association between chromosome 9p21 variants and the ankle-brachial index identified by a meta-analysis of 21 genome-wide association studies. Circ Cardiovasc Genet. 2012;5(1):100–12.PubMedCrossRef

101.

O’Donnell CJ, Kavousi M, Smith AV, Kardia SL, Feitosa MF, Hwang SJ, et al. Genome-wide association study for coronary artery calcification with follow-up in myocardial infarction. Circulation. 2011;124(25):2855–64.PubMedCrossRefPubMedCentral

102.

Consortium CAD, Deloukas P, Kanoni S, Willenborg C, Farrall M, Assimes TL, et al. Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet. 2013;45(1):25–33.

103.

Schunkert H, Konig IR, Kathiresan S, Reilly MP, Assimes TL, Holm H, et al. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet. 2011;43(4):333–8.PubMedCrossRefPubMedCentral

104.

de Vries PS, Kavousi M, Ligthart S, Uitterlinden AG, Hofman A, Franco OH, et al. Incremental predictive value of 152 single nucleotide polymorphisms in the 10-year risk prediction of incident coronary heart disease: the Rotterdam Study. Int J Epidemiol. 2015;44(2):682–8.PubMedCrossRef

105.

Steenaard RV, Ligthart S, Stolk L, Peters MJ, van Meurs JB, Uitterlinden AG, et al. Tobacco smoking is associated with methylation of genes related to coronary artery disease. Clin Epigenetics. 2015;14:7.

106.

Braun KV, Dhana K, de Vries PS, Voortman T, van Meurs JB, Uitterlinden AG, et al. Epigenome-wide association study (EWAS) on lipids: the Rotterdam Study. Clin Epigenetics. 2017;9:15.PubMedCrossRefPubMedCentral

107.

Ghanbari M, de Vries PS, de Looper H, Peters MJ, Schurmann C, Yaghootkar H, et al. A genetic variant in the seed region of miR-4513 shows pleiotropic effects on lipid and glucose homeostasis, blood pressure, and coronary artery disease. Hum Mutat. 2014;35(12):1524–31.PubMedCrossRef

108.

Ghanbari M, Sedaghat S, de Looper HW, Hofman A, Erkeland SJ, Franco OH, et al. The association of common polymorphisms in miR-196a2 with waist to hip ratio and miR-1908 with serum lipid and glucose. Obesity (Silver Spring). 2015;23(2):495–503.CrossRef

109.

Ghanbari M, Franco OH, de Looper HW, Hofman A, Erkeland SJ, Dehghan A. Genetic variations in microRNA-binding sites affect microRNA-mediated regulation of several genes associated with cardio-metabolic phenotypes. Circ Cardiovasc Genet. 2015;8(3):473–86.PubMedCrossRef

110.

Praagman J, de Jonge EA, Kiefte-de Jong JC, Beulens JW, Sluijs I, Schoufour JD, et al. Dietary saturated fatty acids and coronary heart disease risk in a dutch middle-aged and elderly population. Arterioscler Thromb Vasc Biol. 2016;36(9):2011–8.PubMedCrossRef

111.

Muka T, Blekkenhorst LC, Lewis JR, Prince RL, Erler NS, Hofman A, et al. Dietary fat composition, total body fat and regional body fat distribution in two Caucasian populations of middle-aged and older adult women. Clin Nutr. 2017;36(5):1411–9.PubMedCrossRef

112.

Kraja B, Muka T, Ruiter R, de Keyser CE, Hofman A, Franco OH, et al. Dietary fiber intake modifies the positive association between n-3 PUFA intake and colorectal cancer risk in a caucasian population. J Nutr. 2015;145(8):1709–16.PubMedCrossRef

113.

Muka T, Kraja B, Ruiter R, de Keyser CE, Hofman A, Stricker BH, et al. Dietary polyunsaturated fatty acids intake modifies the positive association between serum total cholesterol and colorectal cancer risk: the Rotterdam Study. J Epidemiol Community Health. 2016;70(9):881–7.PubMedCrossRef

114.

Muka T, Kiefte-de Jong JC, Hofman A, Dehghan A, Rivadeneira F, Franco OH. Polyunsaturated fatty acids and serum C-reactive protein: the Rotterdam study. Am J Epidemiol. 2015;181(11):846–56.PubMedCrossRef

115.

Muka T, Kraja B, Ruiter R, Lahousse L, de Keyser CE, Hofman A, et al. Dietary mineral intake and lung cancer risk: the Rotterdam Study. Eur J Nutr. 2017;56(4):1637–46.PubMedCrossRef

116.

van Lee L, Geelen A, Kiefte-de Jong JC, Witteman JC, Hofman A, Vonk N, et al. Adherence to the Dutch dietary guidelines is inversely associated with 20-year mortality in a large prospective cohort study. Eur J Clin Nutr. 2016;70(2):262–8.PubMedCrossRef

117.

de Jonge EA, Rivadeneira F, Erler NS, Hofman A, Uitterlinden AG, Franco OH, et al. Dietary patterns in an elderly population and their relation with bone mineral density: the Rotterdam Study. Eur J Nutr. 2016. doi:10.1007/s00394-016-1297-7.PubMed

118.

de Jonge EA, Kiefte-de Jong JC, Hofman A, Uitterlinden AG, Kieboom BC, Voortman T, et al. Dietary patterns explaining differences in bone mineral density and hip structure in the elderly: the Rotterdam Study. Am J Clin Nutr. 2017;105(1):203–11.PubMedCrossRef

119.

Berendsen AA, Kang JH, van de Rest O, Jankovic N, Kampman E, Kiefte-de Jong JC, et al. Association of adherence to a healthy diet with cognitive decline in European and American older adults: a meta-analysis within the CHANCES Consortium. Dement Geriatr Cogn Disord. 2017;43(3–4):215–27.PubMedCrossRefPubMedCentral

120.

Jankovic N, Geelen A, Winkels RM, Mwungura B, Fedirko V, Jenab M, et al. Adherence to the WCRF/AICR dietary recommendations for cancer prevention and risk of cancer in elderly from Europe and the United States: a meta-analysis within the CHANCES project. Cancer Epidemiol Biomark Prev. 2017;26(1):136–44.CrossRef

121.

Dhana K, Koolhaas CM, Berghout MA, Peeters A, Ikram MA, Tiemeier H, et al. Physical activity types and life expectancy with and without cardiovascular disease: the Rotterdam Study. J Public Health (Oxf). 2016. doi:10.1093/pubmed/fdw110.

122.

Koolhaas CM, Dhana K, Golubic R, Schoufour JD, Hofman A, van Rooij FJ, et al. Physical activity types and coronary heart disease risk in middle-aged and elderly persons: the Rotterdam Study. Am J Epidemiol. 2016;183(8):729–38.PubMedCrossRef

123.

Koolhaas CM, Dhana K, van Rooij FJ, Kocevska D, Hofman A, Franco OH, et al. Sedentary time assessed by actigraphy and mortality: the Rotterdam Study. Prev Med. 2017;95:59–65.PubMedCrossRef

124.

Leening MJ, Kavousi M, Heeringa J, van Rooij FJ, Verkroost-van Heemst J, Deckers JW, et al. Methods of data collection and definitions of cardiac outcomes in the Rotterdam Study. Eur J Epidemiol. 2012;27(3):173–85.PubMedCrossRefPubMedCentral

125.

Smith NL, Chen MH, Dehghan A, Strachan DP, Basu S, Soranzo N, et al. Novel associations of multiple genetic loci with plasma levels of factor VII, factor VIII, and von Willebrand factor: the CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium. Circulation. 2010;121(12):1382–92.PubMedCrossRefPubMedCentral

126.

Dehghan A, Kardys I, de Maat MP, Uitterlinden AG, Sijbrands EJ, Bootsma AH, et al. Genetic variation, C-reactive protein levels, and incidence of diabetes. Diabetes. 2007;56(3):872–8.PubMedCrossRef

127.

Hruby A, Ngwa JS, Renstrom F, Wojczynski MK, Ganna A, Hallmans G, et al. Higher magnesium intake is associated with lower fasting glucose and insulin, with no evidence of interaction with select genetic loci, in a meta-analysis of 15 CHARGE Consortium Studies. J Nutr. 2013;143(3):345–53.PubMedCrossRefPubMedCentral

128.

Kanoni S, Nettleton JA, Hivert MF, Ye Z, van Rooij FJ, Shungin D, et al. Total zinc intake may modify the glucose-raising effect of a zinc transporter (SLC30A8) variant: a 14-cohort meta-analysis. Diabetes. 2011;60(9):2407–16.PubMedCrossRefPubMedCentral

129.

Nettleton JA, Hivert MF, Lemaitre RN, McKeown NM, Mozaffarian D, Tanaka T, et al. Meta-analysis investigating associations between healthy diet and fasting glucose and insulin levels and modification by loci associated with glucose homeostasis in data from 15 cohorts. Am J Epidemiol. 2013;177(2):103–15.PubMedCrossRef

130.

Straus SM, Kors JA, De Bruin ML, van der Hooft CS, Hofman A, Heeringa J, et al. Prolonged QTc interval and risk of sudden cardiac death in a population of older adults. J Am Coll Cardiol. 2006;47(2):362–7.PubMedCrossRef

131.

Kardys I, Deckers JW, Stricker BH, Vletter WB, Hofman A, Witteman J. Distribution of echocardiographic parameters and their associations with cardiovascular risk factors in the Rotterdam Study. Eur J Epidemiol. 2010;25(7):481–90.PubMedCrossRefPubMedCentral

132.

Klipstein-Grobusch K, den Breeijen JH, Goldbohm RA, Geleijnse JM, Hofman A, Grobbee DE, et al. Dietary assessment in the elderly: validation of a semiquantitative food frequency questionnaire. Eur J Clin Nutr. 1998;52(8):588–96.PubMedCrossRef

133.

Feunekes GI, Van Staveren WA, De Vries JH, Burema J, Hautvast JG. Relative and biomarker-based validity of a food-frequency questionnaire estimating intake of fats and cholesterol. Am J Clin Nutr. 1993;58(4):489–96.PubMed

134.

Goldbohm RA, van den Brandt PA, Brants HA, van’t Veer P, Al M, Sturmans F, et al. Validation of a dietary questionnaire used in a large-scale prospective cohort study on diet and cancer. Eur J Clin Nutr. 1994;48(4):253–65.PubMed

135.

Goldbohm RA, van ‘t Veer P, van den Brandt PA, van ‘t Hof MA, Brants HA, Sturmans F, et al. Reproducibility of a food frequency questionnaire and stability of dietary habits determined from five annually repeated measurements. Eur J Clin Nutr. 1995;49(6):420–9.PubMed

136.

Siebelink E, Geelen A, de Vries JH. Self-reported energy intake by FFQ compared with actual energy intake to maintain body weight in 516 adults. Br J Nutr. 2011;106(2):274–81.PubMedCrossRef

137.

Caspersen CJ, Bloemberg BP, Saris WH, Merritt RK, Kromhout D. The prevalence of selected physical activities and their relation with coronary heart disease risk factors in elderly men: the Zutphen Study, 1985. Am J Epidemiol. 1991;133(11):1078–92.PubMedCrossRef

138.

Stel VS, Smit JH, Pluijm SM, Visser M, Deeg DJ, Lips P. Comparison of the LASA Physical Activity Questionnaire with a 7-day diary and pedometer. J Clin Epidemiol. 2004;57(3):252–8.PubMedCrossRef

139.

Voorrips LE, Ravelli AC, Dongelmans PC, Deurenberg P, Van Staveren WA. A physical activity questionnaire for the elderly. Med Sci Sports Exerc. 1991;23(8):974–9.PubMedCrossRef

140.

Searle SD, Mitnitski A, Gahbauer EA, Gill TM, Rockwood K. A standard procedure for creating a frailty index. BMC Geriatr. 2008;30(8):24.CrossRef

141.

Mitnitski AB, Mogilner AJ, Rockwood K. Accumulation of deficits as a proxy measure of aging. Sci World J. 2001;08(1):323–36.CrossRef

142.

Schoufour JD, Erler NS, Jaspers L, Kiefte-de Jong JC, Voortman T, Ziere G, et al. Design of a frailty index among community living middle-aged and older people: the Rotterdam Study. Maturitas. 2017;97:14–20.PubMedCrossRef

143.

Grosso G, Micek A, Godos J, Sciacca S, Pajak A, Martinez-Gonzalez MA, et al. Coffee consumption and risk of all-cause, cardiovascular, and cancer mortality in smokers and non-smokers: a dose-response meta-analysis. Eur J Epidemiol. 2016;31(12):1191–205.PubMedCrossRef

144.

Aune D, Sen A, Henriksen T, Saugstad OD, Tonstad S. Physical activity and the risk of gestational diabetes mellitus: a systematic review and dose-response meta-analysis of epidemiological studies. Eur J Epidemiol. 2016;31(10):967–97.PubMedCrossRefPubMedCentral

145.

Bellavia A, Tektonidis TG, Orsini N, Wolk A, Larsson SC. Quantifying the benefits of Mediterranean diet in terms of survival. Eur J Epidemiol. 2016;31(5):527–30.PubMedCrossRef

146.

Byberg S, Agyemang C, Zwisler AD, Krasnik A, Norredam M. Cardiovascular disease incidence and survival: are migrants always worse off? Eur J Epidemiol. 2016;31(7):667–77.PubMedCrossRef

147.

DeRoo L, Skjaerven R, Wilcox A, Klungsoyr K, Wikstrom AK, Morken NH, et al. Placental abruption and long-term maternal cardiovascular disease mortality: a population-based registry study in Norway and Sweden. Eur J Epidemiol. 2016;31(5):501–11.PubMedCrossRef

148.

Jain P, Danaei G, Robins JM, Manson JE, Hernan MA. Smoking cessation and long-term weight gain in the Framingham Heart Study: an application of the parametric g-formula for a continuous outcome. Eur J Epidemiol. 2016;31(12):1223–9.PubMedCrossRef

149.

Kunutsor SK, Khan H, Laukkanen JA. Serum magnesium and risk of new onset heart failure in men: the Kuopio Ischemic Heart Disease Study. Eur J Epidemiol. 2016;31(10):1035–43.PubMedCrossRef

150.

Lukic M, Licaj I, Lund E, Skeie G, Weiderpass E, Braaten T. Coffee consumption and the risk of cancer in the Norwegian Women and Cancer (NOWAC) Study. Eur J Epidemiol. 2016;31(9):905–16.PubMedCrossRef

151.

O’Doherty MG, Cairns K, O’Neill V, Lamrock F, Jorgensen T, Brenner H, et al. Effect of major lifestyle risk factors, independent and jointly, on life expectancy with and without cardiovascular disease: results from the Consortium on Health and Ageing Network of Cohorts in Europe and the United States (CHANCES). Eur J Epidemiol. 2016;31(5):455–68.PubMedCrossRefPubMedCentral

152.

Pongiglione B, De Stavola BL, Kuper H, Ploubidis GB. Disability and all-cause mortality in the older population: evidence from the English Longitudinal Study of Ageing. Eur J Epidemiol. 2016;31(8):735–46.PubMedCrossRefPubMedCentral

153.

Artaud F, Singh-Manoux A, Dugravot A, Tavernier B, Tzourio C, Elbaz A. Body mass index trajectories and functional decline in older adults: three-City Dijon cohort study. Eur J Epidemiol. 2016;31(1):73–83.PubMedCrossRef

154.

Aune D, Norat T, Leitzmann M, Tonstad S, Vatten LJ. Physical activity and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis. Eur J Epidemiol. 2015;30(7):529–42.PubMedCrossRef

155.

Bobak M, Malyutina S, Horvat P, Pajak A, Tamosiunas A, Kubinova R, et al. Alcohol, drinking pattern and all-cause, cardiovascular and alcohol-related mortality in Eastern Europe. Eur J Epidemiol. 2016;31(1):21–30.PubMedCrossRef

156.

Demissei BG, Postmus D, Valente MA, van der Harst P, van Gilst WH, Van den Heuvel ER, et al. Should non-cardiovascular mortality be considered in the SCORE model? Findings from the prevention of renal and vascular end-stage disease (PREVEND) cohort. Eur J Epidemiol. 2015;30(1):47–56.PubMedCrossRef

157.

di Giuseppe R, Kuhn T, Hirche F, Buijsse B, Dierkes J, Fritsche A, et al. Plasma fibroblast growth factor 23 and risk of cardiovascular disease: results from the EPIC-Germany case-cohort study. Eur J Epidemiol. 2015;30(2):131–41.PubMedCrossRef

158.

Endes S, Schaffner E, Caviezel S, Dratva J, Autenrieth CS, Wanner M, et al. Physical activity is associated with lower arterial stiffness in older adults: results of the SAPALDIA 3 Cohort Study. Eur J Epidemiol. 2016;31(3):275–85.PubMedCrossRef

159.

Engeset D, Braaten T, Teucher B, Kuhn T, Bueno-de-Mesquita H, Leenders M, et al. Fish consumption and mortality in the European prospective investigation into cancer and nutrition cohort. Eur J Epidemiol. 2015;30(1):57–70.PubMedCrossRef

160.

Gaillard R. Maternal obesity during pregnancy and cardiovascular development and disease in the offspring. Eur J Epidemiol. 2015;30(11):1141–52.PubMedCrossRefPubMedCentral

161.

Little MP, Zablotska LB, Brenner AV, Lipshultz SE. Circulatory disease mortality in the Massachusetts tuberculosis fluoroscopy cohort study. Eur J Epidemiol. 2016;31(3):287–309.PubMedCrossRef

162.

Liu XM, Liu YJ, Zhan J, He QQ. Overweight, obesity and risk of all-cause and cardiovascular mortality in patients with type 2 diabetes mellitus: a dose-response meta-analysis of prospective cohort studies. Eur J Epidemiol. 2015;30(1):35–45.PubMedCrossRef

163.

Mursu J, Nurmi T, Voutilainen S, Tuomainen TP, Virtanen JK. The association between serum 25-hydroxyvitamin D-3 concentration and risk of disease death in men: modification by magnesium intake. Eur J Epidemiol. 2015;30(4):343–7.PubMedCrossRef

164.

Wald NJ, Luteijn JM, Morris JK, Taylor D, Oppenheimer P. Cost-benefit analysis of the polypill in the primary prevention of myocardial infarction and stroke. Eur J Epidemiol. 2016;31(4):415–26.PubMedCrossRefPubMedCentral

165.

Zhang C, Qin YY, Wei X, Yu FF, Zhou YH, He J. Tea consumption and risk of cardiovascular outcomes and total mortality: a systematic review and meta-analysis of prospective observational studies. Eur J Epidemiol. 2015;30(2):103–13.PubMedCrossRef

166.

Flohil SC, van der Leest RJ, Dowlatshahi EA, Hofman A, de Vries E, Nijsten T. Prevalence of actinic keratosis and its risk factors in the general population: the Rotterdam Study. J Investig Dermatol. 2013;133(8):1971–8.PubMedCrossRef

167.

Verkouteren JA, Pardo LM, Uitterlinden AG, Hofman A, Nijsten T. Common variants affecting susceptibility to develop multiple basal cell carcinomas. J Investig Dermatol. 2015;135(8):2135–8.PubMedCrossRef

168.

Pardo LM, Li WQ, Hwang SJ, Verkouteren JA, Hofman A, Uitterlinden AG, et al. Genome-wide association studies of multiple keratinocyte cancers. PLoS ONE. 2017;12(1):e0169873.PubMedCrossRefPubMedCentral

169.

Jacobs LC, Hamer MA, Gunn DA, Deelen J, Lall JS, van Heemst D, et al. A genome-wide association study identifies the skin color genes IRF4, MC1R, ASIP, and BNC2 influencing facial pigmented spots. J Investig Dermatol. 2015;135(7):1735–42.PubMedCrossRef

170.

Zhong K, Verkouteren JA, Jacobs LC, Uitterlinden AG, Hofman A, Liu F, et al. Pigmentation-independent susceptibility loci for actinic keratosis highlighted by compound heterozygosity analysis. J Investig Dermatol. 2017;137(1):77–84.PubMedCrossRef

171.

Jacobs LC, Wollstein A, Lao O, Hofman A, Klaver CC, Uitterlinden AG, et al. Comprehensive candidate gene study highlights UGT1A and BNC2 as new genes determining continuous skin color variation in Europeans. Hum Genet. 2013;132(2):147–58.PubMedCrossRef

172.

Liu F, Visser M, Duffy DL, Hysi PG, Jacobs LC, Lao O, et al. Genetics of skin color variation in Europeans: genome-wide association studies with functional follow-up. Hum Genet. 2015;134(8):823–35.PubMedCrossRefPubMedCentral

173.

Liu F, Hamer MA, Deelen J, Lall JS, Jacobs L, van Heemst D, et al. The MC1R gene and youthful looks. Curr Biol. 2016;26(9):1213–20.PubMedCrossRef

174.

Hamer MA, Pardo LM, Jacobs LC, Ikram MA, Laven JS, Kayser M, et al. Lifestyle and physiological factors associated with facial wrinkling in men and women. J Invest Dermatol. 2017;137(8):1692–9.PubMedCrossRef

175.

Dowlatshahi EA, Kavousi M, Nijsten T, Ikram MA, Hofman A, Franco OH, et al. Psoriasis is not associated with atherosclerosis and incident cardiovascular events: the Rotterdam Study. J Investig Dermatol. 2013;133(10):2347–54.PubMedCrossRef

176.

van der Voort EA, Koehler EM, Dowlatshahi EA, Hofman A, Stricker BH, Janssen HL, et al. Psoriasis is independently associated with nonalcoholic fatty liver disease in patients 55 years old or older: results from a population-based study. J Am Acad Dermatol. 2014;70(3):517–24.PubMedCrossRef

177.

van der Voort EA, Koehler EM, Nijsten T, Stricker BH, Hofman A, Janssen HL, et al. Increased prevalence of advanced liver fibrosis in patients with psoriasis: a cross-sectional analysis from the Rotterdam Study. Acta Derm Venereol. 2016;96(2):213–7.PubMedCrossRef

178.

Chaker L, van den Berg ME, Niemeijer MN, Franco OH, Dehghan A, Hofman A, et al. Thyroid function and sudden cardiac death: a prospective population-based cohort study. Circulation. 2016;134(10):713–22.PubMedCrossRef

179.

Chaker L, Sedaghat S, Hoorn EJ, Elzen WP, Gussekloo J, Hofman A, et al. The association of thyroid function and the risk of kidney function decline: a population-based cohort study. Eur J Endocrinol. 2016;175(6):653–60.PubMedCrossRef

180.

Khan SR, Chaker L, Ruiter R, Aerts JG, Hofman A, Dehghan A, et al. Thyroid function and cancer risk: the Rotterdam Study. J Clin Endocrinol Metab. 2016;101(12):5030–6.PubMedCrossRef

181.

Chaker L, Buitendijk GH, Dehghan A, Medici M, Hofman A, Vingerling JR, et al. Thyroid function and age-related macular degeneration: a prospective population-based cohort study—the Rotterdam Study. BMC Med. 2015;13:94.PubMedCrossRefPubMedCentral

182.

Medici M, Direk N, Visser WE, Korevaar TI, Hofman A, Visser TJ, et al. Thyroid function within the normal range and the risk of depression: a population-based cohort study. J Clin Endocrinol Metab. 2014;99(4):1213–9.PubMedCrossRef

183.

Chaker L, Wolters FJ, Bos D, Korevaar TI, Hofman A, van der Lugt A, et al. Thyroid function and the risk of dementia: the Rotterdam Study. Neurology. 2016;87(16):1688–95.PubMedCrossRef

184.

Bano A, Chaker L, Plompen EP, Hofman A, Dehghan A, Franco OH, et al. Thyroid function and the risk of nonalcoholic fatty liver disease: the Rotterdam Study. J Clin Endocrinol Metab. 2016;101(8):3204–11.PubMedCrossRef

185.

Chaker L, Ligthart S, Korevaar TI, Hofman A, Franco OH, Peeters RP, et al. Thyroid function and risk of type 2 diabetes: a population-based prospective cohort study. BMC Med. 2016;14(1):150.PubMedCrossRefPubMedCentral

186.

Bano A, Chaker L, Darweesh SK, Korevaar TI, Mattace-Raso FU, Dehghan A, et al. Gait patterns associated with thyroid function: the Rotterdam Study. Sci Rep. 2016;14(6):38912.CrossRef

187.

Blum MR, Bauer DC, Collet TH, Fink HA, Cappola AR, da Costa BR, et al. Subclinical thyroid dysfunction and fracture risk: a meta-analysis. JAMA. 2015;313(20):2055–65.PubMedCrossRefPubMedCentral

188.

Chaker L, Baumgartner C, den Elzen WP, Ikram MA, Blum MR, Collet TH, et al. Subclinical hypothyroidism and the risk of stroke events and fatal stroke: an individual participant data analysis. J Clin Endocrinol Metab. 2015;100(6):2181–91.PubMedCrossRefPubMedCentral

189.

Chaker L, Baumgartner C, den Elzen WP, Collet TH, Ikram MA, Blum MR, et al. Thyroid function within the reference range and the risk of stroke: an individual participant data analysis. J Clin Endocrinol Metab. 2016;101(11):4270–82.PubMedCrossRefPubMedCentral

190.

Asvold BO, Vatten LJ, Bjoro T, Bauer DC, Bremner A, Cappola AR, et al. Thyroid function within the normal range and risk of coronary heart disease: an individual participant data analysis of 14 cohorts. JAMA Intern Med. 2015;175(6):1037–47.PubMedCrossRefPubMedCentral

191.

Chaker L, Korevaar TI, Medici M, Uitterlinden AG, Hofman A, Dehghan A, et al. Thyroid function characteristics and determinants: the Rotterdam Study. Thyroid. 2016;26(9):1195–204.PubMedCrossRef

192.

Porcu E, Medici M, Pistis G, Volpato CB, Wilson SG, Cappola AR, et al. A meta-analysis of thyroid-related traits reveals novel loci and gender-specific differences in the regulation of thyroid function. PLoS Genet. 2013;9(2):e1003266.PubMedCrossRefPubMedCentral

193.

Medici M, Porcu E, Pistis G, Teumer A, Brown SJ, Jensen RA, et al. Identification of novel genetic Loci associated with thyroid peroxidase antibodies and clinical thyroid disease. PLoS Genet. 2014;10(2):e1004123.PubMedCrossRefPubMedCentral

194.

Schultheiss UT, Teumer A, Medici M, Li Y, Daya N, Chaker L, et al. A genetic risk score for thyroid peroxidase antibodies associates with clinical thyroid disease in community-based populations. J Clin Endocrinol Metab. 2015;100(5):E799–807.PubMedCrossRefPubMedCentral

195.

Abouzeid M, Wikstrom K, Peltonen M, Lindstrom J, Borodulin K, Rahkonen O, et al. Secular trends and educational differences in the incidence of type 2 diabetes in Finland, 1972–2007. Eur J Epidemiol. 2015;30(8):649–59.PubMedCrossRef

196.

Dallmeier D, Klenk J, Peter RS, Denkinger M, Peter R, Rapp K, et al. A prospective assessment of cardiac biomarkers for hemodynamic stress and necrosis and the risk of falls among older people: the ActiFE study. Eur J Epidemiol. 2016;31(4):427–35.PubMedCrossRef

197.

Kunutsor SK, Apekey TA, Laukkanen JA. Association of serum total osteocalcin with type 2 diabetes and intermediate metabolic phenotypes: systematic review and meta-analysis of observational evidence. Eur J Epidemiol. 2015;30(8):599–614.PubMedCrossRef

198.

Oei L, Koromani F, Breda SJ, Schousboe JT, Clark EM, van Meurs J, et al. Osteoporotic vertebral fracture prevalence varies widely between radiological assessment methods: the Rotterdam Study. J Bone Miner Res. 2017. doi:10.1002/jbmr.3220.PubMed

199.

Muka T, Trajanoska K, Kiefte-de Jong JC, Oei L, Uitterlinden AG, Hofman A, et al. The association between metabolic syndrome, bone mineral density, hip bone geometry and fracture risk: the Rotterdam Study. PLoS ONE. 2015;10(6):e0129116.PubMedCrossRefPubMedCentral

200.

Muka T, de Jonge EA, Kiefte-de Jong JC, Uitterlinden AG, Hofman A, Dehghan A, et al. The influence of serum uric acid on bone mineral density, hip geometry, and fracture risk: the Rotterdam Study. J Clin Endocrinol Metab. 2016;101(3):1113–22.PubMedCrossRef

201.

de Jonge EA, Kiefte-de Jong JC, Campos-Obando N, Booij L, Franco OH, Hofman A, et al. Dietary vitamin A intake and bone health in the elderly: the Rotterdam Study. Eur J Clin Nutr. 2015;69(12):1360–8.PubMedCrossRef

202.

de Jonge EAL, Koromani F, Hofman A, Uitterlinden AG, Franco OH, Rivadeneira F, et al. Dietary acid load, trabecular bone integrity, and mineral density in an ageing population: the Rotterdam study. Osteoporos Int. 2017;28(8):2357–65.PubMedCrossRefPubMedCentral

203.

de Jonge EA, Kiefte-de Jong JC, de Groot LC, Voortman T, Schoufour JD, Zillikens MC, et al. Development of a food group-based diet score and its association with bone mineral density in the elderly: the Rotterdam Study. Nutrients. 2015;7(8):6974–90.PubMedCrossRefPubMedCentral

204.

Campos-Obando N, Koek WNH, Hooker ER, van der Eerden BC, Pols HA, Hofman A, et al. Serum phosphate is associated with fracture risk: the Rotterdam Study and MrOS. J Bone Miner Res. 2017;32(6):1182–93.PubMedCrossRef

205.

Bergink AP, Zillikens MC, Van Leeuwen JP, Hofman A, Uitterlinden AG, van Meurs JB. 25-Hydroxyvitamin D and osteoarthritis: a meta-analysis including new data. Semin Arthritis Rheum. 2016;45(5):539–46.PubMedCrossRef

206.

Saberi Hosnijeh F, Siebuhr AS, Uitterlinden AG, Oei EH, Hofman A, Karsdal MA, et al. Association between biomarkers of tissue inflammation and progression of osteoarthritis: evidence from the Rotterdam study cohort. Arthritis Res Ther. 2016;01(18):81.CrossRef

207.

Hoeven TA, Kavousi M, Ikram MA, van Meurs JB, Bindels PJ, Hofman A, et al. Markers of atherosclerosis in relation to presence and progression of knee osteoarthritis: a population-based cohort study. Rheumatology (Oxford). 2015;54(9):1692–8.CrossRef

208.

Saberi Hosnijeh F, Zuiderwijk ME, Versteeg M, Smeele HT, Hofman A, Uitterlinden AG, et al. Cam deformity and acetabular dysplasia as risk factors for hip osteoarthritis. Arthritis Rheumatol. 2017;69(1):86–93.PubMedCrossRef

209.

Smith JG, Felix JF, Morrison AC, Kalogeropoulos A, Trompet S, Wilk JB, et al. Discovery of genetic variation on chromosome 5q22 associated with mortality in heart failure. PLoS Genet. 2016;12(5):e1006034.PubMedCrossRefPubMedCentral

210.

Pilling LC, Joehanes R, Kacprowski T, Peters M, Jansen R, Karasik D, et al. Gene transcripts associated with muscle strength: a CHARGE meta-analysis of 7781 persons. Physiol Genom. 2016;48(1):1–11.CrossRef

211.

de Kruijf M, Bos D, Huygen FJ, Niessen WJ, Tiemeier H, Hofman A, et al. Structural brain alterations in community dwelling individuals with chronic joint pain. AJNR Am J Neuroradiol. 2016;37(3):430–8.PubMedCrossRef

212.

de Kruijf M, Stolk L, Zillikens MC, de Rijke YB, Bierma-Zeinstra SM, Hofman A, et al. Lower sex hormone levels are associated with more chronic musculoskeletal pain in community-dwelling elderly women. Pain. 2016;157(7):1425–31.PubMedCrossRef

213.

de Kruijf M, Verlinden VJ, Huygen FJ, Hofman A, van der Geest JN, Uitterlinden AG, et al. Chronic joint pain in the lower body is associated with gait differences independent from radiographic osteoarthritis. Gait Posture. 2015;42(3):354–9.PubMedCrossRef

214.

Verlinden VJA, de Kruijf M, Bierma-Zeinstra SMA, Hofman A, Uitterlinden AG, Ikram MA, et al. Asymptomatic radiographic hip osteoarthritis is associated with gait differences, especially in women: a population-based study. Gait Posture. 2017;54:248–54.PubMedCrossRef

215.

de Kruijf M, Peters MJ, Jacobs LC, Tiemeier H, Nijsten T, Hofman A, et al. Determinants for quantitative sensory testing and the association with chronic musculoskeletal pain in the general elderly population. Pain Pract. 2016;16(7):831–41.PubMedCrossRef

216.

Castano-Betancourt MC, Evans DS, Ramos YF, Boer CG, Metrustry S, Liu Y, et al. Novel genetic variants for cartilage thickness and hip osteoarthritis. PLoS Genet. 2016;12(10):e1006260.PubMedCrossRefPubMedCentral

217.

Warner SC, van Meurs JB, Schiphof D, Bierma-Zeinstra SM, Hofman A, Uitterlinden AG, et al. Genome-wide association scan of neuropathic pain symptoms post total joint replacement highlights a variant in the protein-kinase C gene. Eur J Hum Genet. 2017;25(4):446–51.PubMedCrossRef

218.

Zillikens MC, Demissie S, Hsu YH, Yerges-Armstrong LM, Chou WC, Stolk L, et al. Large meta-analysis of genome-wide association studies identifies five loci for lean body mass. Nat Commun. 2017;8(1):80.PubMedCrossRefPubMedCentral

219.

Zheng HF, Forgetta V, Hsu YH, Estrada K, Rosello-Diez A, Leo PJ, et al. Whole-genome sequencing identifies EN1 as a determinant of bone density and fracture. Nature. 2015;526(7571):112–7.PubMedCrossRefPubMedCentral

220.

Morris JA, Tsai PC, Joehanes R, Zheng J, Trajanoska K, Soerensen M, et al. Epigenome-wide Association of DNA methylation in whole blood with bone mineral density. J Bone Miner Res. 2017;32(8):1644–50.PubMedCrossRefPubMedCentral

221.

Marouli E, Graff M, Medina-Gomez C, Lo KS, Wood AR, Kjaer TR, et al. Rare and low-frequency coding variants alter human adult height. Nature. 2017;542(7640):186–90.PubMedCrossRefPubMedCentral

222.

Cohen JC, Horton JD, Hobbs HH. Human fatty liver disease: old questions and new insights. Science. 2011;332(6037):1519–23.PubMedCrossRefPubMedCentral

223.

Ratziu V, Giral P, Charlotte F, Bruckert E, Thibault V, Theodorou I, et al. Liver fibrosis in overweight patients. Gastroenterology. 2000;118(6):1117–23.PubMedCrossRef

224.

Hamaguchi M, Kojima T, Itoh Y, Harano Y, Fujii K, Nakajima T, et al. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am J Gastroenterol. 2007;102(12):2708–15.PubMedCrossRef

225.

Sandrin L, Fourquet B, Hasquenoph JM, Yon S, Fournier C, Mal F, et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol. 2003;29(12):1705–13.PubMedCrossRef

226.

Talwalkar JA, Kurtz DM, Schoenleber SJ, West CP, Montori VM. Ultrasound-based transient elastography for the detection of hepatic fibrosis: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2007;5(10):1214–20.PubMedCrossRef

227.

Koehler EM, Schouten JN, Hansen BE, van Rooij FJ, Hofman A, Stricker BH, et al. Prevalence and risk factors of non-alcoholic fatty liver disease in the elderly: results from the Rotterdam study. J Hepatol. 2012;57(6):1305–11.PubMedCrossRef

228.

de Keyser CE, Koehler EM, Schouten JN, Visser LE, Hofman A, Janssen HL, et al. Statin therapy is associated with a reduced risk of non-alcoholic fatty liver in overweight individuals. Dig Liver Dis. 2014;46(8):720–5.PubMedCrossRef

229.

Koehler EM, Schouten JN, Hansen BE, Hofman A, Stricker BH, Janssen HL. External validation of the fatty liver index for identifying nonalcoholic fatty liver disease in a population-based study. Clin Gastroenterol Hepatol. 2013;11(9):1201–4.PubMedCrossRef

230.

Koehler EM, Sanna D, Hansen BE, van Rooij FJ, Heeringa J, Hofman A, et al. Serum liver enzymes are associated with all-cause mortality in an elderly population. Liver Int. 2014;34(2):296–304.PubMedCrossRef

231.

Plompen EP, Hansen BE, Schouten JN, Darwish Murad S, Loth DW, Brouwer WP, et al. Interferon gamma receptor 2 gene variants are associated with liver fibrosis in the general population: the Rotterdam Study. Gut. 2015;64(4):692–4.PubMedCrossRef

232.

Modi AA, Feld JJ, Park Y, Kleiner DE, Everhart JE, Liang TJ, et al. Increased caffeine consumption is associated with reduced hepatic fibrosis. Hepatology. 2010;51(1):201–9.PubMedCrossRefPubMedCentral

233.

Alferink LJM, Fittipaldi J, Kiefte-de Jong JC, Taimr P, Hansen BE, Metselaar HJ, et al. Coffee and herbal tea consumption is associated with lower liver stiffness in the general population: The Rotterdam study. J Hepatol. 2017;67(2):339–48.PubMedCrossRef

234.

Aune D, Norat T, Vatten LJ. Body mass index, abdominal fatness and the risk of gallbladder disease. Eur J Epidemiol. 2015;30(9):1009–19.PubMedCrossRef

235.

Aune D, Vatten LJ, Boffetta P. Tobacco smoking and the risk of gallbladder disease. Eur J Epidemiol. 2016;31(7):643–53.PubMedCrossRefPubMedCentral

236.

Schrijvers EM, Verhaaren BF, Koudstaal PJ, Hofman A, Ikram MA, Breteler MM. Is dementia incidence declining?: trends in dementia incidence since 1990 in the Rotterdam Study. Neurology. 2012;78(19):1456–63.PubMedCrossRef

237.

Wieberdink RG, Ikram MA, Hofman A, Koudstaal PJ, Breteler MM. Trends in stroke incidence rates and stroke risk factors in Rotterdam, the Netherlands from 1990 to 2008. Eur J Epidemiol. 2012;27(4):287–95.PubMedCrossRefPubMedCentral

238.

Darweesh SK, Koudstaal PJ, Stricker BH, Hofman A, Ikram MA. Trends in the incidence of Parkinson Disease in the general population: the Rotterdam Study. Am J Epidemiol. 2016;183(11):1018–26.PubMedCrossRef

239.

Hanewinckel R, Drenthen J, van Oijen M, Hofman A, van Doorn PA, Ikram MA. Prevalence of polyneuropathy in the general middle-aged and elderly population. Neurology. 2016;87(18):1892–8.PubMedCrossRef

240.

Hoogendam YY, Hofman A, van der Geest JN, van der Lugt A, Ikram MA. Patterns of cognitive function in aging: the Rotterdam Study. Eur J Epidemiol. 2014;29(2):133–40.PubMedCrossRef

241.

Verlinden VJ, van der Geest JN, Hoogendam YY, Hofman A, Breteler MM, Ikram MA. Gait patterns in a community-dwelling population aged 50 years and older. Gait Posture. 2013;37(4):500–5.PubMedCrossRef

242.

van Velsen EF, Vernooij MW, Vrooman HA, van der Lugt A, Breteler MM, Hofman A, et al. Brain cortical thickness in the general elderly population: the Rotterdam Scan Study. Neurosci Lett. 2013;29(550):189–94.CrossRef

243.

de Groot M, Cremers LG, Ikram MA, Hofman A, Krestin GP, van der Lugt A, et al. White matter degeneration with aging: longitudinal diffusion MR imaging analysis. Radiology. 2016;279(2):532–41.PubMedCrossRef

244.

Ikram MA, Vrooman HA, Vernooij MW, van der Lijn F, Hofman A, van der Lugt A, et al. Brain tissue volumes in the general elderly population. The Rotterdam Scan Study. Neurobiol Aging. 2008;29(6):882–90.PubMedCrossRef

245.

Verlinden VJ, van der Geest JN, Hofman A, Ikram MA. Cognition and gait show a distinct pattern of association in the general population. Alzheimers Dement. 2014;10(3):328–35.PubMedCrossRef

246.

Verlinden VJ, de Groot M, Cremers LG, van der Geest JN, Hofman A, Niessen WJ, et al. Tract-specific white matter microstructure and gait in humans. Neurobiol Aging. 2016;43:164–73.PubMedCrossRef

247.

Verlinden VJ, van der Geest JN, Heeringa J, Hofman A, Ikram MA. Gait shows a sex-specific pattern of associations with daily functioning in a community-dwelling population of older people. Gait Posture. 2015;41(1):119–24.PubMedCrossRef

248.

Darweesh SK, Wolters FJ, Hofman A, Stricker BH, Koudstaal PJ, Ikram MA. Simple test of manual dexterity can help to identify persons at high risk for neurodegenerative diseases in the community. J Gerontol A Biol Sci Med Sci. 2017;72(1):75–81.PubMedCrossRef

249.

Darweesh SK, Verlinden VJ, Adams HH, Uitterlinden AG, Hofman A, Stricker BH, et al. Genetic risk of Parkinson’s disease in the general population. Parkinsonism Relat Disord. 2016;29:54–9.PubMedCrossRef

250.

Ghanbari M, Darweesh SK, de Looper HW, van Luijn MM, Hofman A, Ikram MA, et al. Genetic variants in microRNAs and their binding sites are associated with the risk of Parkinson disease. Hum Mutat. 2016;37(3):292–300.PubMedCrossRef

251.

Vlasov V, Darweesh SKL, Stricker BH, Franco OH, Ikram MK, Kavousi M, et al. Subclinical vascular disease and the risk of parkinsonism: the Rotterdam Study. Parkinsonism Relat Disord. 2017. doi:10.1016/j.parkreldis.2017.06.022.PubMed

252.

Wolters FJ, Zonneveld HI, Hofman A, van der Lugt A, Koudstaal PJ, Vernooij MW, et al. Cerebral perfusion and the risk of dementia: a population-based study. Circulation. 2017;136(8):719–28.PubMedCrossRef

253.

Bos D, Bozorgpourniazi A, Mutlu U, Kavousi M, Vernooij MW, Moelker A, et al. Aortic valve calcification and risk of stroke: the Rotterdam Study. Stroke. 2016;47(11):2859–61.PubMedCrossRef

254.

Evans TE, O’Sullivan MJ, de Groot M, Niessen WJ, Hofman A, Krestin GP, et al. White matter microstructure improves stroke risk prediction in the general population. Stroke. 2016;47(11):2756–62.PubMedCrossRef

255.

Wolters FJ, Mattace-Raso FU, Koudstaal PJ, Hofman A, Ikram MA. Heart brain connection collaborative research G. Orthostatic hypotension and the long-term risk of dementia: a population-based study. PLoS Med. 2016;13(10):e1002143.PubMedCrossRefPubMedCentral

256.

Portegies ML, Mirza SS, Verlinden VJ, Hofman A, Koudstaal PJ, Swanson SA, et al. Mid- to late-life trajectories of blood pressure and the risk of stroke: the Rotterdam Study. Hypertension. 2016;67(6):1126–32.PubMed

257.

Mirza SS, Wolters FJ, Swanson SA, Koudstaal PJ, Hofman A, Tiemeier H, et al. 10-year trajectories of depressive symptoms and risk of dementia: a population-based study. Lancet Psychiatry. 2016;3(7):628–35.PubMedCrossRef

258.

Wolters FJ, van der Lee SJ, Koudstaal PJ, van Duijn CM, Hofman A, Ikram MK, et al. Parental family history of dementia in relation to subclinical brain disease and dementia risk. Neurology. 2017;88(17):1642–9.PubMedCrossRef

259.

Hanewinckel R, Ikram MA, Franco OH, Hofman A, Drenthen J, van Doorn PA. High body mass and kidney dysfunction relate to worse nerve function, even in adults without neuropathy. J Peripher Nerv Syst. 2017;22(2):112–20.PubMedCrossRef

260.

Hanewinckel R, Drenthen J, Ligthart S, Dehghan A, Franco OH, Hofman A, et al. Metabolic syndrome is related to polyneuropathy and impaired peripheral nerve function: a prospective population-based cohort study. J Neurol Neurosurg Psychiatry. 2016;87(12):1336–42.PubMedCrossRef

261.

Wen KX, Mutlu U, Ikram MK, Kavousi M, Klaver CC, Tiemeier H, et al. The retinal microcirculation in migraine: the Rotterdam Study. Cephalalgia. 2017;01:333102417708774.

262.

Darweesh SK, Verlinden VJ, Stricker BH, Hofman A, Koudstaal PJ, Ikram MA. Trajectories of prediagnostic functioning in Parkinson’s disease. Brain. 2017;140(Pt 2):429–41.PubMedCrossRef

263.

Verlinden VJA, van der Geest JN, de Bruijn R, Hofman A, Koudstaal PJ, Ikram MA. Trajectories of decline in cognition and daily functioning in preclinical dementia. Alzheimers Dement. 2016;12(2):144–53.PubMedCrossRef

264.

Verlinden VJA, van der Geest JN, Hofman A, Niessen WJ, van der Lugt A, Vernooij MW, et al. Brain MRI-markers associate differentially with cognitive versus functional decline leading to dementia. J Am Geriatr Soc. 2017;65(6):1258–66.PubMedCrossRef

265.

Sims R, van der Lee SJ, Naj AC, Bellenguez C, Badarinarayan N, Jakobsdottir J, et al. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer’s disease. Nat Genet. 2017;49(9):1373–84.PubMedCrossRef

266.

Ikram MA, Zonneveld HI, Roshchupkin G, Smith AV, Franco OH, Sigurdsson S, et al. Heritability and genome-wide associations studies of cerebral blood flow in the general population. J Cereb Blood Flow Metab. 2017:271678X17715861.

267.

Holstege H, van der Lee SJ, Hulsman M, Wong TH, van Rooij JG, Weiss M, et al. Characterization of pathogenic SORL1 genetic variants for association with Alzheimer’s disease: a clinical interpretation strategy. Eur J Hum Genet. 2017;25(8):973–81.PubMedCrossRefPubMedCentral

268.

Hibar DP, Adams HH, Jahanshad N, Chauhan G, Stein JL, Hofer E, et al. Novel genetic loci associated with hippocampal volume. Nat Commun. 2017;18(8):13624.CrossRef

269.

Adams HH, Hibar DP, Chouraki V, Stein JL, Nyquist PA, Renteria ME, et al. Novel genetic loci underlying human intracranial volume identified through genome-wide association. Nat Neurosci. 2016;19(12):1569–82.PubMedCrossRefPubMedCentral

270.

de Bruijn RF, Bos MJ, Portegies ML, Hofman A, Franco OH, Koudstaal PJ, et al. The potential for prevention of dementia across two decades: the prospective, population-based Rotterdam Study. BMC Med. 2015;21(13):132.CrossRef

271.

Bos MJ, Koudstaal PJ, Hofman A, Ikram MA. Modifiable etiological factors and the burden of stroke from the Rotterdam study: a population-based cohort study. PLoS Med. 2014;11(4):e1001634.PubMedCrossRefPubMedCentral

272.

Bos D, Ikram MA, Leening MJG, Ikram MK. The revised framingham stroke risk profile in a primary prevention population: the Rotterdam Study. Circulation. 2017;135(22):2207–9.PubMedCrossRef

273.

Darweesh SK, Koudstaal PJ, Stricker BH, Hofman A, Steyerberg EW, Ikram MA. Predicting Parkinson disease in the community using a nonmotor risk score. Eur J Epidemiol. 2016;31(7):679–84.PubMedCrossRefPubMedCentral

274.

Qian J, Wolters FJ, Beiser A, Haan M, Ikram MA, Karlawish J, et al. APOE-related risk of mild cognitive impairment and dementia for prevention trials: an analysis of four cohorts. PLoS Med. 2017;14(3):e1002254.PubMedCrossRefPubMedCentral

275.

Ott A, Breteler MM, van Harskamp F, Claus JJ, van der Cammen TJ, Grobbee DE, et al. Prevalence of Alzheimer’s disease and vascular dementia: association with education. The Rotterdam study. BMJ. 1995;310(6985):970–3.PubMedCrossRefPubMedCentral

276.

Ruitenberg A, Ott A, van Swieten JC, Hofman A, Breteler MM. Incidence of dementia: does gender make a difference? Neurobiol Aging. 2001;22(4):575–80.PubMedCrossRef

277.

de Rijk MC, Breteler MM, Graveland GA, Ott A, Grobbee DE, van der Meche FG, et al. Prevalence of Parkinson’s disease in the elderly: the Rotterdam Study. Neurology. 1995;45(12):2143–6.PubMedCrossRef

278.

Bos MJ, Schipper CM, Koudstaal PJ, Witteman JC, Hofman A, Breteler MM. High serum C-reactive protein level is not an independent predictor for stroke: the Rotterdam Study. Circulation. 2006;114(15):1591–8.PubMedCrossRef

279.

Hollander M, Koudstaal PJ, Bots ML, Grobbee DE, Hofman A, Breteler MM. Incidence, risk, and case fatality of first ever stroke in the elderly population. The Rotterdam Study. J Neurol Neurosurg Psychiatry. 2003;74(3):317–21.PubMedCrossRefPubMedCentral

280.

Bos MJ, van Rijn MJ, Witteman JC, Hofman A, Koudstaal PJ, Breteler MM. Incidence and prognosis of transient neurological attacks. JAMA. 2007;298(24):2877–85.PubMedCrossRef

281.

Killgore WD, Glahn DC, Casasanto DJ. Development and validation of the design organization test (DOT): a rapid screening instrument for assessing visuospatial ability. J Clin Exp Neuropsychol. 2005;27(4):449–59.PubMedCrossRef

282.

Trouillas P, Takayanagi T, Hallett M, Currier RD, Subramony SH, Wessel K, et al. International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. The Ataxia Neuropharmacology Committee of the World Federation of Neurology. J Neurol Sci. 1997;145(2):205–11.PubMedCrossRef

283.

Loehrer E, Vernooij MW, van der Lugt A, Hofman A, Ikram MA. Migraine and cerebral blood flow in the general population. Cephalalgia. 2015;35(2):190–8.PubMedCrossRef

284.

Breteler MM, van Swieten JC, Bots ML, Grobbee DE, Claus JJ, van den Hout JH, et al. Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study. Neurology. 1994;44(7):1246–52.PubMedCrossRef

285.

Ikram MA, van der Lugt A, Niessen WJ, Krestin GP, Koudstaal PJ, Hofman A, et al. The Rotterdam Scan Study: design and update up to 2012. Eur J Epidemiol. 2011;26(10):811–24.PubMedCrossRefPubMedCentral

286.

Bennett DA, Brayne C, Feigin VL, Barker-Collo S, Brainin M, Davis D, et al. Development of the standards of reporting of neurological disorders (STROND) checklist: a guideline for the reporting of incidence and prevalence studies in neuroepidemiology. Eur J Epidemiol. 2015;30(7):569–76.PubMedCrossRef

287.

Cations M, Withall A, Low LF, Draper B. What is the role of modifiable environmental and lifestyle risk factors in young onset dementia? Eur J Epidemiol. 2016;31(2):107–24.PubMedCrossRef

288.

Cohen-Manheim I, Doniger GM, Sinnreich R, Simon ES, Pinchas R, Aviv A, et al. Increased attrition of leukocyte telomere length in young adults is associated with poorer cognitive function in midlife. Eur J Epidemiol. 2016;31(2):147–57.PubMedCrossRef

289.

Fang F, Hallmarker U, James S, Ingre C, Michaelsson K, Ahlbom A, et al. Amyotrophic lateral sclerosis among cross-country skiers in Sweden. Eur J Epidemiol. 2016;31(3):247–53.PubMedCrossRef

290.

Gallo V, Vanacore N, Bueno-de-Mesquita HB, Vermeulen R, Brayne C, Pearce N, et al. Physical activity and risk of amyotrophic lateral sclerosis in a prospective cohort study. Eur J Epidemiol. 2016;31(3):255–66.PubMedCrossRefPubMedCentral

291.

Gazibara T, Pekmezovic T, Kisic-Tepavcevic D, Svetel M, Tomic A, Stankovic I, et al. Incidence and prediction of falls in Parkinson’s disease: a prospective cohort study. Eur J Epidemiol. 2015;30(4):349–52.PubMedCrossRef

292.

Goudsmit J. The incubation period of Alzheimer’s disease and the timing of tau versus amyloid misfolding and spreading within the brain. Eur J Epidemiol. 2016;31(2):99–105.PubMedCrossRefPubMedCentral

293.

Hanewinckel R, van Oijen M, Ikram MA, van Doorn PA. The epidemiology and risk factors of chronic polyneuropathy. Eur J Epidemiol. 2016;31(1):5–20.PubMedCrossRef

294.

Ikram MA, VanderWeele TJ. A proposed clinical and biological interpretation of mediated interaction. Eur J Epidemiol. 2015;30(10):1115–8.PubMedCrossRefPubMedCentral

295.

Kishimoto H, Ohara T, Hata J, Ninomiya T, Yoshida D, Mukai N, et al. The long-term association between physical activity and risk of dementia in the community: the Hisayama Study. Eur J Epidemiol. 2016;31(3):267–74.PubMedCrossRef

296.

Kunutsor SK, Khan H, Nyyssonen K, Laukkanen JA. Is lipoprotein (a) protective of dementia? Eur J Epidemiol. 2016;31(11):1149–52.PubMedCrossRef

297.

Langballe EM, Ask H, Holmen J, Stordal E, Saltvedt I, Selbaek G, et al. Alcohol consumption and risk of dementia up to 27 years later in a large, population-based sample: the HUNT study, Norway. Eur J Epidemiol. 2015;30(9):1049–56.PubMedCrossRefPubMedCentral

298.

Marin B, Logroscino G, Boumediene F, Labrunie A, Couratier P, Babron MC, et al. Clinical and demographic factors and outcome of amyotrophic lateral sclerosis in relation to population ancestral origin. Eur J Epidemiol. 2016;31(3):229–45.PubMedCrossRef

299.

Nevalainen O, Simola M, Ansakorpi H, Raitanen J, Artama M, Isojarvi J, et al. Epilepsy, excess deaths and years of life lost from external causes. Eur J Epidemiol. 2016;31(5):445–53.PubMedCrossRef

300.

Rakers F, Schiffner R, Rupprecht S, Brandstadt A, Witte OW, Walther M, et al. Rapid weather changes are associated with increased ischemic stroke risk: a case-crossover study. Eur J Epidemiol. 2016;31(2):137–46.PubMedCrossRef

301.

Simeon V, Chiodini P, Mattiello A, Sieri S, Panico C, Brighenti F, et al. Dietary glycemic load and risk of cognitive impairment in women: findings from the EPIC-Naples cohort. Eur J Epidemiol. 2015;30(5):425–33.PubMedCrossRef

302.

Watad A, Azrielant S, Soriano A, Bracco D, Abu Much A, Amital H. Association between seasonal factors and multiple sclerosis. Eur J Epidemiol. 2016;31(11):1081–9.PubMedCrossRef

303.

Zhang ZZ, Xu GL, Wei YY, Zhu WS, Liu XF. Nut consumption and risk of stroke. Eur J Epidemiol. 2015;30(3):189–96.PubMedCrossRef

304.

Fritsche LG, Igl W, Bailey JN, Grassmann F, Sengupta S, Bragg-Gresham JL, et al. A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants. Nat Genet. 2016;48(2):134–43.PubMedCrossRef

305.

Grassmann F, Kiel C, Zimmermann ME, Gorski M, Grassmann V, Stark K, et al. Genetic pleiotropy between age-related macular degeneration and 16 complex diseases and traits. Genome Med. 2017;9(1):29.PubMedCrossRefPubMedCentral

306.

Ghanbari M, Erkeland SJ, Xu L, Colijn JM, Franco OH, Dehghan A, et al. Genetic variants in microRNAs and their binding sites within gene 3’UTRs associate with susceptibility to age-related macular degeneration. Hum Mutat. 2017;38(7):827–38.PubMedCrossRef

307.

Joachim N, Colijn JM, Kifley A, Lee KE, Buitendijk GH, Klein BE, et al. Five-year progression of unilateral age-related macular degeneration to bilateral involvement: the Three Continent AMD Consortium report. Br J Ophthalmol. 2017;101(9):1185–92.PubMedCrossRef

308.

Buitendijk GH, Hooghart AJ, Brussee C, de Jong PT, Hofman A, Vingerling JR, et al. Epidemiology of reticular pseudodrusen in age-related macular degeneration: the Rotterdam Study. Invest Ophthalmol Vis Sci. 2016;57(13):5593–601.PubMedCrossRef

309.

Fan Q, Verhoeven VJ, Wojciechowski R, Barathi VA, Hysi PG, Guggenheim JA, et al. Meta-analysis of gene-environment-wide association scans accounting for education level identifies additional loci for refractive error. Nat Commun. 2016;29(7):11008.CrossRef

310.

Fan Q, Guo X, Tideman JW, Williams KM, Yazar S, Hosseini SM, et al. Childhood gene-environment interactions and age-dependent effects of genetic variants associated with refractive error and myopia: the CREAM Consortium. Sci Rep. 2016;13(6):25853.CrossRef

311.

Khawaja AP, Springelkamp H, Creuzot-Garcher C, Delcourt C, Hofman A, Hohn R, et al. Associations with intraocular pressure across Europe: the European Eye Epidemiology (E3) Consortium. Eur J Epidemiol. 2016;31(11):1101–11.PubMedCrossRefPubMedCentral

312.

Nag A, Lu H, Arno M, Iglesias AI, Bonnemaijer P, Broer L, et al. Evaluation of the myocilin mutation Gln368Stop demonstrates reduced penetrance for glaucoma in European populations. Ophthalmology. 2017;124(4):547–53.PubMedCrossRef

313.

Iglesias AI, van der Lee SJ, Bonnemaijer PWM, Hohn R, Nag A, Gharahkhani P, et al. Haplotype reference consortium panel: Practical implications of imputations with large reference panels. Hum Mutat. 2017;38(8):1025–32.PubMedCrossRef

314.

Mutlu U, Adams HH, Hofman A, Lugt A, Klaver CC, Vernooij MW, et al. Retinal microvascular calibers are associated with enlarged perivascular spaces in the brain. Stroke. 2016;47(5):1374–6.PubMedCrossRef

315.

Mutlu U, Cremers LG, de Groot M, Hofman A, Niessen WJ, van der Lugt A, et al. Retinal microvasculature and white matter microstructure: the Rotterdam Study. Neurology. 2016;87(10):1003–10.PubMedCrossRef

316.

Mutlu U, Ikram MA, Hofman A, de Jong PT, Klaver CC, Ikram MK. N-terminal Pro-B-type natriuretic peptide is related to retinal microvascular damage: the Rotterdam Study. Arterioscler Thromb Vasc Biol. 2016;36(8):1698–702.PubMedCrossRef

317.

Mutlu U, Ikram MA, Hofman A, de Jong PT, Uitterlinden AG, Klaver CC, et al. Vitamin D and retinal microvascular damage: the Rotterdam Study. Medicine (Baltimore). 2016;95(49):e5477.CrossRef

318.

Mutlu U, Ikram MK, Wolters FJ, Hofman A, Klaver CC, Ikram MA. Retinal microvasculature is associated with long-term survival in the general adult dutch population. Hypertension. 2016;67(2):281–7.PubMed

319.

Bianchi M, Clavenna A, Piovani D, Bonati M. In Italy anti-asthmatic drug prescription is not always a reliable proxy of asthma. Eur J Epidemiol. 2016;31(5):531–2.PubMedCrossRef

320.

Delcourt C, Korobelnik JF, Buitendijk GHS, Foster PJ, Hammond CJ, Piermarocchi S, et al. Ophthalmic epidemiology in Europe: the “European Eye Epidemiology” (E3) consortium. Eur J Epidemiol. 2016;31(2):197–210.PubMedCrossRef

321.

Tideman JWL, Polling JR, Voortman T, Jaddoe VWV, Uitterlinden AG, Hofman A, et al. Low serum vitamin D is associated with axial length and risk of myopia in young children. Eur J Epidemiol. 2016;31(5):491–9.PubMedCrossRefPubMedCentral

322.

Williams KM, Verhoeven VJM, Cumberland P, Bertelsen G, Wolfram C, Buitendijk GHS, et al. Prevalence of refractive error in Europe: the European Eye Epidemiology (E-3) Consortium. Eur J Epidemiol. 2015;30(4):305–15.PubMedCrossRefPubMedCentral

323.

Direk N, Perez HS, Akoudad S, Verhaaren BF, Niessen WJ, Hofman A, et al. Markers of cerebral small vessel disease and severity of depression in the general population. Psychiatry Res. 2016;30(253):1–6.CrossRef

324.

Jovanova O, Aarts N, Noordam R, Carola-Zillikens M, Hofman A, Tiemeier H. Vitamin D serum levels are cross-sectionally but not prospectively associated with late-life depression. Acta Psychiatr Scand. 2017;135(3):185–94.PubMedCrossRef

325.

Direk N, Dekker MJ, Luik AI, Kirschbaum C, de Rijke YB, Hofman A, et al. The very low-dose dexamethasone suppression test in the general population: a cross-sectional study. PLoS ONE. 2016;11(10):e0164348.PubMedCrossRefPubMedCentral

326.

Direk N, Williams S, Smith JA, Ripke S, Air T, Amare AT, et al. An analysis of two genome-wide association meta-analyses identifies a new locus for broad depression phenotype. Biol Psychiatry. 2017;82(5):322–9.PubMedCrossRef

327.

Gottlieb DJ, Hek K, Chen TH, Watson NF, Eiriksdottir G, Byrne EM, et al. Novel loci associated with usual sleep duration: the CHARGE Consortium Genome-Wide Association Study. Mol Psychiatry. 2015;20(10):1232–9.PubMedCrossRef

328.

Hek K, Demirkan A, Lahti J, Terracciano A, Teumer A, Cornelis MC, et al. A genome-wide association study of depressive symptoms. Biol Psychiatry. 2013;73(7):667–78.PubMedCrossRef

329.

Saavedra Perez HC, Direk N, Hofman A, Vernooij MW, Tiemeier H, Ikram MA. Silent brain infarcts: a cause of depression in the elderly? Psychiatry Res. 2013;211(2):180–2.PubMedCrossRef

330.

Freak-Poli R, Mirza SS, Franco OH, Ikram MA, Hofman A, Tiemeier H. Positive affect is not associated with incidence of cardiovascular disease: a population-based study of older persons. Prev Med. 2015;74:14–20.PubMedCrossRef

331.

Krijthe BP, Walter S, Newson RS, Hofman A, Hunink MG, Tiemeier H. Is positive affect associated with survival? A population-based study of elderly persons. Am J Epidemiol. 2011;173(11):1298–307.PubMedCrossRef

332.

Luijendijk HJ, van den Berg JF, Dekker MJ, van Tuijl HR, Otte W, Smit F, et al. Incidence and recurrence of late-life depression. Arch Gen Psychiatry. 2008;65(12):1394–401.PubMedCrossRef

333.

Hek K, Direk N, Newson RS, Hofman A, Hoogendijk WJ, Mulder CL, et al. Anxiety disorders and salivary cortisol levels in older adults: a population-based study. Psychoneuroendocrinology. 2013;38(2):300–5.PubMedCrossRef

334.

Van Den Berg JF, Van Rooij FJ, Vos H, Tulen JH, Hofman A, Miedema HM, et al. Disagreement between subjective and actigraphic measures of sleep duration in a population-based study of elderly persons. J Sleep Res. 2008;17(3):295–302.CrossRef

335.

Luik AI, Zuurbier LA, Whitmore H, Hofman A, Tiemeier H. REM sleep and depressive symptoms in a population-based study of middle-aged and elderly persons. J Sleep Res. 2015;24(3):305–8.PubMedCrossRef

336.

Zuurbier LA, Luik AI, Hofman A, Franco OH, Van Someren EJ, Tiemeier H. Fragmentation and stability of circadian activity rhythms predict mortality: the Rotterdam study. Am J Epidemiol. 2015;181(1):54–63.PubMedCrossRef

337.

Newson RS, Hek K, Luijendijk HJ, Hofman A, Witteman JC, Tiemeier H. Atherosclerosis and incident depression in late life. Arch Gen Psychiatry. 2010;67(11):1144–51.PubMedCrossRef

338.

Direk N, Koudstaal PJ, Hofman A, Ikram MA, Hoogendijk WJ, Tiemeier H. Cerebral hemodynamics and incident depression: the Rotterdam Study. Biol Psychiatry. 2012;72(4):318–23.PubMedCrossRef

339.

van den Berg JF, Miedema HM, Tulen JH, Hofman A, Neven AK, Tiemeier H. Sex differences in subjective and actigraphic sleep measures: a population-based study of elderly persons. Sleep. 2009;32(10):1367–75.PubMedCrossRefPubMedCentral

340.

Luik AI, Noteboom J, Zuurbier LA, Whitmore H, Hofman A, Tiemeier H. Sleep apnea severity and depressive symptoms in a population-based study. Sleep Health. 2015;1:128–32.PubMedCrossRef

341.

Portegies ML, Bos MJ, Koudstaal PJ, Hofman A, Tiemeier HW, Ikram MA. Anxiety and the risk of stroke: the Rotterdam Study. Stroke. 2016;47(4):1120–3.PubMedCrossRef

342.

Mirza SS, Ikram MA, Bos D, Mihaescu R, Hofman A, Tiemeier H. Mild cognitive impairment and risk of depression and anxiety: a population-based study. Alzheimers Dement. 2017;13(2):130–9.PubMedCrossRef

343.

Newson RS, Boelen PA, Hek K, Hofman A, Tiemeier H. The prevalence and characteristics of complicated grief in older adults. J Affect Disord. 2011;132(1–2):231–8.PubMedCrossRef

344.

Saavedra Perez HC, Ikram MA, Direk N, Prigerson HG, Freak-Poli R, Verhaaren BF, et al. Cognition, structural brain changes and complicated grief. A population-based study. Psychol Med. 2015;45(7):1389–99.PubMedCrossRef

345.

Freak-Poli R, Kirkman M, De Castro Lima G, Direk N, Franco OH, Tiemeier H. Sexual activity and physical tenderness in older adults: cross-sectional prevalence and associated characteristics. J Sex Med. 2017;14(7):918–27.PubMedCrossRef

346.

Freak-Poli R, De Castro Lima G, Direk N, Jaspers L, Pitts M, Hofman A, et al. Happiness, rather than depression, is associated with sexual behaviour in partnered older adults. Age Ageing. 2017;46(1):101–7.PubMed

347.

Sajjad A, Freak-Poli RL, Hofman A, Roza SJ, Ikram MA, Tiemeier H. Subjective measures of health and all-cause mortality—the Rotterdam Study. Psychol Med. 2017;13:1–10.

348.

Bjorkenstam C, Andersson G, Dalman C, Cochran S, Kosidou K. Suicide in married couples in Sweden: is the risk greater in same-sex couples? Eur J Epidemiol. 2016;31(7):685–90.PubMedCrossRef

349.

Bloechliger M, Ceschi A, Ruegg S, Jick SS, Meier CR, Bodmer M. Lifestyle factors, psychiatric and neurologic comorbidities, and drug use associated with incident seizures among adult patients with depression: a population-based nested case-control study. Eur J Epidemiol. 2016;31(11):1113–22.PubMedCrossRef

350.

Fang F, Fall K, Valdimarsdottir U. Stress and cancer: nordic pieces to the complex puzzle. Eur J Epidemiol. 2015;30(7):525–7.PubMedCrossRef

351.

Rostila M, Saarela J, Kawachi I, Hjern A. Testing the anniversary reaction: causal effects of bereavement in a nationwide follow-up study from Sweden. Eur J Epidemiol. 2015;30(3):239–47.PubMedCrossRef

352.

Sieurin J, Gustavsson P, Weibull CE, Feldman AL, Petzinger GM, Gatz M, et al. Personality traits and the risk for Parkinson disease: a prospective study. Eur J Epidemiol. 2016;31(2):169–75.PubMedCrossRef

353.

Stenholm S, Kivimaki M, Jylha M, Kawachi I, Westerlund H, Pentti J, et al. Trajectories of self-rated health in the last 15 years of life by cause of death. Eur J Epidemiol. 2016;31(2):177–85.PubMedCrossRef

354.

Hofman A, Darwish Murad S, van Duijn CM, Franco OH, Goedegebure A, Ikram MA, et al. The Rotterdam Study: 2014 objectives and design update. Eur J Epidemiol. 2013;28(11):889–926.PubMedCrossRef

355.

van Durme YM, Verhamme KM, Stijnen T, van Rooij FJ, Van Pottelberge GR, Hofman A, et al. Prevalence, incidence, and lifetime risk for the development of COPD in the elderly: the Rotterdam study. Chest. 2009;135(2):368–77.PubMedCrossRef

356.

Terzikhan N, Verhamme KM, Hofman A, Stricker BH, Brusselle GG, Lahousse L. Prevalence and incidence of COPD in smokers and non-smokers: the Rotterdam Study. Eur J Epidemiol. 2016;31(8):785–92.PubMedCrossRefPubMedCentral

357.

Artigas MS, Loth DW, Wain LV, Gharib SA, Obeidat M, Tang WB, et al. Genome-wide association and large-scale follow up identifies 16 new loci influencing lung function. Nat Genet. 2011;43(11):1082–90.CrossRefPubMedCentral

358.

Hancock DB, Eijgelsheim M, Wilk JB, Gharib SA, Loehr LR, Marciante KD, et al. Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function. Nat Genet. 2010;42(1):45–52.PubMedCrossRef

359.

Hobbs BD, de Jong K, Lamontagne M, Bosse Y, Shrine N, Artigas MS, et al. Genetic loci associated with chronic obstructive pulmonary disease overlap with loci for lung function and pulmonary fibrosis. Nat Genet. 2017;49(3):426–32.PubMedCrossRefPubMedCentral

360.

Loth DW, Soler Artigas M, Gharib SA, Wain LV, Franceschini N, Koch B, et al. Genome-wide association analysis identifies six new loci associated with forced vital capacity. Nat Genet. 2014;46(7):669–77.PubMedCrossRefPubMedCentral

361.

Obeidat M, Hao K, Bosse Y, Nickle DC, Nie Y, Postma DS, et al. Molecular mechanisms underlying variations in lung function: a systems genetics analysis. Lancet Respir Med. 2015;3(10):782–95.PubMedCrossRefPubMedCentral

362.

Campos-Obando N, Castano-Betancourt MC, Oei L, Franco OH, Stricker BH, Brusselle GG, et al. Bone mineral density and chronic lung disease mortality: the Rotterdam Study. J Clin Endocrinol Metab. 2014;99(5):1834–42.PubMedCrossRef

363.

Lahousse L, van den Bouwhuijsen QJ, Loth DW, Joos GF, Hofman A, Witteman JC, et al. Chronic obstructive pulmonary disease and lipid core carotid artery plaques in the elderly: the Rotterdam Study. Am J Respir Crit Care Med. 2013;187(1):58–64.PubMedCrossRef

364.

Lahousse L, Tiemeier H, Ikram MA, Brusselle GG. Chronic obstructive pulmonary disease and cerebrovascular disease: a comprehensive review. Respir Med. 2015;109(11):1371–80.PubMedCrossRef

365.

Lahousse L, Verlinden VJ, van der Geest JN, Joos GF, Hofman A, Stricker BH, et al. Gait patterns in COPD: the Rotterdam Study. Eur Respir J. 2015;46(1):88–95.PubMedCrossRef

366.

Lahousse L, Vernooij MW, Darweesh SK, Akoudad S, Loth DW, Joos GF, et al. Chronic obstructive pulmonary disease and cerebral microbleeds. The Rotterdam Study. Am J Respir Crit Care Med. 2013;188(7):783–8.PubMedCrossRef

367.

Portegies ML, Lahousse L, Joos GF, Hofman A, Koudstaal PJ, Stricker BH, et al. Chronic obstructive pulmonary disease and the risk of stroke. The Rotterdam Study. Am J Respir Crit Care Med. 2016;193(3):251–8.PubMedCrossRef

368.

Lahousse L, Niemeijer MN, van den Berg ME, Rijnbeek PR, Joos GF, Hofman A, et al. Chronic obstructive pulmonary disease and sudden cardiac death: the Rotterdam study. Eur Heart J. 2015;36(27):1754–61.PubMedCrossRef

369.

Lahousse L, Ziere G, Verlinden VJ, Zillikens MC, Uitterlinden AG, Rivadeneira F, et al. Risk of frailty in elderly with COPD: a population-based study. J Gerontol A Biol Sci Med Sci. 2016;71(5):689–95.PubMedCrossRef

370.

Lahousse L, Maes B, Ziere G, Loth DW, Verlinden VJ, Zillikens MC, et al. Adverse outcomes of frailty in the elderly: the Rotterdam Study. Eur J Epidemiol. 2014;29(6):419–27.PubMedCrossRef

371.

Pitter G, Ludvigsson JF, Romor P, Zanier L, Zanotti R, Simonato L, et al. Antibiotic exposure in the first year of life and later treated asthma, a population based birth cohort study of 143,000 children. Eur J Epidemiol. 2016;31(1):85–94.PubMedCrossRef

372.

Sevelsted A, Pipper CB, Bisgaard H. Stable admission rate for acute asthma in Danish children since 1977. Eur J Epidemiol. 2016;31(3):325–9.PubMedCrossRef

373.

Soderholm M, Inghammar M, Hedblad B, Egesten A, Engstrom G. Incidence of stroke and stroke subtypes in chronic obstructive pulmonary disease. Eur J Epidemiol. 2016;31(2):159–68.PubMedCrossRef

374.

Sudan M, Arah OA, Olsen J, Kheifets L. Reported associations between asthma and acute lymphoblastic leukemia: insights from a hybrid simulation study. Eur J Epidemiol. 2016;31(6):593–602.PubMedCrossRef

375.

Soininen P, Kangas AJ, Wurtz P, Suna T, Ala-Korpela M. Quantitative serum nuclear magnetic resonance metabolomics in cardiovascular epidemiology and genetics. Circ Cardiovasc Genet. 2015;8(1):192–206.PubMedCrossRef

376.

Genome of the Netherlands C. Whole-genome sequence variation, population structure and demographic history of the Dutch population. Nat Genet. 2014;46(8):818–25.CrossRef

377.

Minikel EV, Vallabh SM, Lek M, Estrada K, Samocha KE, Sathirapongsasuti JF, et al. Quantifying prion disease penetrance using large population control cohorts. Sci Transl Med. 2016;8(322):322ra9.PubMedCrossRefPubMedCentral

378.

van den Akker EB, Pitts SJ, Deelen J, Moed MH, Potluri S, van Rooij J, et al. Uncompromised 10-year survival of oldest old carrying somatic mutations in DNMT3A and TET2. Blood. 2016;127(11):1512–5.PubMedCrossRefPubMedCentral

379.

Zhernakova DV, Deelen P, Vermaat M, van Iterson M, van Galen M, Arindrarto W, et al. Identification of context-dependent expression quantitative trait loci in whole blood. Nat Genet. 2017;49(1):139–45.PubMedCrossRef

380.

Bonder MJ, Luijk R, Zhernakova DV, Moed M, Deelen P, Vermaat M, et al. Disease variants alter transcription factor levels and methylation of their binding sites. Nat Genet. 2017;49(1):131–8.PubMedCrossRef

381.

Pearce RK, Hawkes CH, Daniel SE. The anterior olfactory nucleus in Parkinson’s disease. Mov Disord. 1995;10(3):283–7.PubMedCrossRef

382.

Liu C, Marioni RE, Hedman AK, Pfeiffer L, Tsai PC, Reynolds LM, et al. A DNA methylation biomarker of alcohol consumption. Mol Psychiatry. 2016. doi:10.1038/mp.2016.192.

383.

Ligthart S, Marzi C, Aslibekyan S, Mendelson MM, Conneely KN, Tanaka T, et al. DNA methylation signatures of chronic low-grade inflammation are associated with complex diseases. Genome Biol. 2016;17(1):255.PubMedCrossRefPubMedCentral

384.

Nano J, Ghanbari M, Wang W, de Vries PS, Dhana K, Muka T, et al. Epigenome-wide association study identifies methylation sites associated with liver enzymes and hepatic steatosis. Gastroenterology. 2017;153(4):1096–106.PubMedCrossRef

385.

Wahl S, Drong A, Lehne B, Loh M, Scott WR, Kunze S, et al. Epigenome-wide association study of body mass index, and the adverse outcomes of adiposity. Nature. 2017;541(7635):81–6.PubMedCrossRef

386.

Huan T, Joehanes R, Schurmann C, Schramm K, Pilling LC, Peters MJ, et al. A whole-blood transcriptome meta-analysis identifies gene expression signatures of cigarette smoking. Hum Mol Genet. 2016;25(21):4611–23.PubMed

387.

Chen BH, Hivert MF, Peters MJ, Pilling LC, Hogan JD, Pham LM, et al. Peripheral blood transcriptomic signatures of fasting glucose and insulin concentrations. Diabetes. 2016;65(12):3794–804.PubMedCrossRef

388.

Morris JA, Tsai PC, Joehanes R, Zheng J, Trajanoska K, Soerensen M, et al. Epigenome-wide association of DNA methylation in whole blood with bone mineral density. J Bone Miner Res. 2017;32(8):1644–50.PubMedCrossRefPubMedCentral

389.

Peters MJ, Joehanes R, Pilling LC, Schurmann C, Conneely KN, Powell J, et al. The transcriptional landscape of age in human peripheral blood. Nat Commun. 2015;22(6):8570.CrossRef

390.

Chen BH, Marioni RE, Colicino E, Peters MJ, Ward-Caviness CK, Tsai PC, et al. DNA methylation-based measures of biological age: meta-analysis predicting time to death. Aging (Albany NY). 2016;8(9):1844–65.CrossRef

391.

Gheorghe M, Schurmann C, Peters MJ, Uitterlinden AG, Hofman A, Biffar R, et al. Blood RNA expression profiles undergo major changes during the seventh decade. Oncotarget. 2016;7(44):71353–61.PubMedPubMedCentral

392.

Zubakov D, Liu F, Kokmeijer I, Choi Y, van Meurs JB, van IJcken WFJ, et al. Human age estimation from blood using mRNA, DNA methylation, DNA rearrangement, and telomere length. Forensic Sci Int Genet. 2016;24:33–43.PubMedCrossRef

393.

Stolk L, Perry JR, Chasman DI, He C, Mangino M, Sulem P, et al. Meta-analyses identify 13 loci associated with age at menopause and highlight DNA repair and immune pathways. Nat Genet. 2012;44(3):260–8.PubMedCrossRefPubMedCentral

394.

Stolk L, Zhai G, van Meurs JB, Verbiest MM, Visser JA, Estrada K, et al. Loci at chromosomes 13, 19 and 20 influence age at natural menopause. Nat Genet. 2009;41(6):645–7.PubMedCrossRefPubMedCentral

395.

Chen CT, Liu CT, Chen GK, Andrews JS, Arnold AM, Dreyfus J, et al. Meta-analysis of loci associated with age at natural menopause in African–American women. Hum Mol Genet. 2014;23(12):3327–42.PubMedCrossRefPubMedCentral

396.

Day FR, Ruth KS, Thompson DJ, Lunetta KL, Pervjakova N, Chasman DI, et al. Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair. Nat Genet. 2015;47(11):1294–303.PubMedCrossRefPubMedCentral

397.

He C, Chasman DI, Dreyfus J, Hwang SJ, Ruiter R, Sanna S, et al. Reproductive aging-associated common genetic variants and the risk of breast cancer. Breast Cancer Res. 2012;14(2):R54.PubMedCrossRefPubMedCentral

398.

Laven JS, Visser JA, Uitterlinden AG, Vermeij WP, Hoeijmakers JH. Menopause: genome stability as new paradigm. Maturitas. 2016;92:15–23.PubMedCrossRef

399.

Perry JR, Corre T, Esko T, Chasman DI, Fischer K, Franceschini N, et al. A genome-wide association study of early menopause and the combined impact of identified variants. Hum Mol Genet. 2013;22(7):1465–72.PubMedCrossRefPubMedCentral

400.

Day FR, Hinds DA, Tung JY, Stolk L, Styrkarsdottir U, Saxena R, et al. Causal mechanisms and balancing selection inferred from genetic associations with polycystic ovary syndrome. Nat Commun. 2015;29(6):8464.CrossRef

401.

Ohlsson C, Wallaschofski H, Lunetta KL, Stolk L, Perry JR, Koster A, et al. Genetic determinants of serum testosterone concentrations in men. PLoS Genet. 2011;7(10):e1002313.PubMedCrossRefPubMedCentral

402.

Coviello AD, Haring R, Wellons M, Vaidya D, Lehtimaki T, Keildson S, et al. A genome-wide association meta-analysis of circulating sex hormone-binding globulin reveals multiple Loci implicated in sex steroid hormone regulation. PLoS Genet. 2012;8(7):e1002805.PubMedCrossRefPubMedCentral

403.

Zhai G, Teumer A, Stolk L, Perry JR, Vandenput L, Coviello AD, et al. Eight common genetic variants associated with serum DHEAS levels suggest a key role in ageing mechanisms. PLoS Genet. 2011;7(4):e1002025.PubMedCrossRefPubMedCentral

404.

Barban N, Jansen R, de Vlaming R, Vaez A, Mandemakers JJ, Tropf FC, et al. Genome-wide analysis identifies 12 loci influencing human reproductive behavior. Nat Genet. 2016;48(12):1462–72.PubMedCrossRefPubMedCentral

405.

Aguirre M, Venema K. The use of fecal samples for studying human obesity. Eur J Epidemiol. 2015;30(9):1067–9.PubMedCrossRef

406.

Benn M, Tybjaerg-Hansen A, Smith GD, Nordestgaard BG. High body mass index and cancer risk-a Mendelian randomisation study. Eur J Epidemiol. 2016;31(9):879–92.PubMedCrossRef

407.

Burgess S, Scott RA, Timpson NJ, Smith GD, Thompson SG, Consortium E-I. Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors. Eur J Epidemiol. 2015;30(7):543–52.PubMedCrossRefPubMedCentral

408.

Dehghan A. Mass spectrometry in epidemiological studies: what are the key considerations? Eur J Epidemiol. 2016;31(8):715–6.PubMedCrossRefPubMedCentral

409.

Kraft P, Aschard H. Finding the missing gene-environment interactions. Eur J Epidemiol. 2015;30(5):353–5.PubMedCrossRefPubMedCentral

410.

Krasnianski A, Heinemann U, Ponto C, Kortt J, Kallenberg K, Varges D, et al. Clinical findings and diagnosis in genetic prion diseases in Germany. Eur J Epidemiol. 2016;31(2):187–96.PubMedCrossRef

411.

Lind MV, Savolainen OI, Ross AB. The use of mass spectrometry for analysing metabolite biomarkers in epidemiology: methodological and statistical considerations for application to large numbers of biological samples. Eur J Epidemiol. 2016;31(8):717–33.PubMedCrossRef

412.

Mattsson K, Jonsson I, Malmqvist E, Larsson HE, Rylander L. Maternal smoking during pregnancy and offspring type 1 diabetes mellitus risk: accounting for HLA haplotype. Eur J Epidemiol. 2015;30(3):231–8.PubMedCrossRef

413.

Medina-Gomez C, Felix JF, Estrada K, Peters MJ, Herrera L, Kruithof CJ, et al. Challenges in conducting genome-wide association studies in highly admixed multi-ethnic populations: the Generation R Study. Eur J Epidemiol. 2015;30(4):317–30.PubMedCrossRefPubMedCentral

414.

Raoult D. Obesity and stools, the “emperor’s new clothing” paradigm. Eur J Epidemiol. 2015;30(9):1071.PubMedCrossRef

415.

Stenzel SL, Ahn J, Boonstra PS, Gruber SB, Mukherjee B. The impact of exposure-biased sampling designs on detection of gene-environment interactions in case-control studies with potential exposure misclassification. Eur J Epidemiol. 2015;30(5):413–23.PubMedCrossRef

416.

Niemeijer MN, van den Berg ME, Leening MJ, Hofman A, Franco OH, Deckers JW, et al. Declining incidence of sudden cardiac death from 1990–2010 in a general middle-aged and elderly population: the Rotterdam Study. Heart Rhythm. 2015;12(1):123–9.PubMedCrossRef

417.

Niemeijer MN, van den Berg ME, Eijgelsheim M, Rijnbeek PR, Stricker BH. Pharmacogenetics of drug-induced QT interval prolongation: an update. Drug Saf. 2015;38(10):855–67.PubMedCrossRefPubMedCentral

418.

Niemeijer MN, van den Berg ME, Deckers JW, Aarnoudse AL, Hofman A, Franco OH, et al. ABCB1 gene variants, digoxin and risk of sudden cardiac death in a general population. Heart. 2015;101(24):1973–9.PubMedCrossRef

419.

Maljuric NM, Noordam R, Aarts N, Niemeijer MN, van den Berg ME, Hofman A, et al. Use of selective serotonin reuptake inhibitors and the heart-rate corrected QT interval in a real-life setting: the population-based Rotterdam Study. Br J Clin Pharmacol. 2015;80(4):698–705.PubMedCrossRefPubMedCentral

420.

Akoudad S, Aarts N, Noordam R, Ikram MA, Tiemeier H, Hofman A, et al. Antidepressant use is associated with an increased risk of developing microbleeds. Stroke. 2016;47(1):251–4.PubMedCrossRef

421.

Noordam R, Aarts N, Leening MJ, Tiemeier H, Franco OH, Hofman A, et al. Use of antidepressants and the risk of myocardial infarction in middle-aged and older adults: a matched case-control study. Eur J Clin Pharmacol. 2016;72(2):211–8.PubMedCrossRef

422.

Noordam R, Avery CL, Visser LE, Stricker BH. Identifying genetic loci affecting antidepressant drug response in depression using drug-gene interaction models. Pharmacogenomics. 2016;17(9):1029–40.PubMedCrossRefPubMedCentral

423.

Aarts N, Noordam R, Hofman A, Tiemeier H, Stricker BH, Visser LE. Self-reported indications for antidepressant use in a population-based cohort of middle-aged and elderly. Int J Clin Pharm. 2016;38(5):1311–7.PubMedCrossRefPubMedCentral

424.

Aarts N, Zuurbier LA, Noordam R, Hofman A, Tiemeier H, Stricker BH, et al. Use of selective serotonin reuptake inhibitors and sleep quality: a population-based study. J Clin Sleep Med. 2016;12(7):989–95.PubMedCrossRefPubMedCentral

425.

Noordam R, van den Berg ME, Niemeijer MN, Aarts N, Leening MJ, Deckers JW, et al. Assessing prolongation of the heart rate corrected QT interval in users of tricyclic antidepressants: advice to use Fridericia rather than Bazett’s correction. J Clin Psychopharmacol. 2015;35(3):260–5.PubMedCrossRef

426.

Noordam R, Sitlani CM, Avery CL, Stewart JD, Gogarten SM, Wiggins KL, et al. A genome-wide interaction analysis of tricyclic/tetracyclic antidepressants and RR and QT intervals: a pharmacogenomics study from the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium. J Med Genet. 2017;54(5):313–23.PubMedCrossRef

427.

Niemeijer MN, van den Berg ME, Franco OH, Hofman A, Kors JA, Stricker BH, et al. Drugs and ventricular repolarization in a general population: the Rotterdam Study. Pharmacoepidemiol Drug Saf. 2015;24(10):1036–41.PubMedCrossRef

428.

Kieboom BC, Niemeijer MN, Leening MJ, van den Berg ME, Franco OH, Deckers JW, et al. Serum magnesium and the risk of death from coronary heart disease and sudden cardiac death. J Am Heart Assoc. 2016;5(1):e002707.PubMedCrossRefPubMedCentral

429.

Kieboom BC, Kiefte-de Jong JC, Eijgelsheim M, Franco OH, Kuipers EJ, Hofman A, et al. Proton pump inhibitors and hypomagnesemia in the general population: a population-based cohort study. Am J Kidney Dis. 2015;66(5):775–82.PubMedCrossRef

430.

Noordam R, Aarts N, de Keyser CE, Hofman A, Stricker BH, Visser LE. Antidepressants with a high serotonin reuptake transporter affinity and serum lipid levels in a population-based study in older adults. J Psychopharmacol. 2015;29(10):1112–8.PubMedCrossRef

431.

Noordam R, Aarts N, Tiemeier H, Hofman A, Stricker BH, Visser LE. Sex-specific association between antidepressant use and body weight in a population-based study in older adults. J Clin Psychiatry. 2015;76(6):e745–51.PubMedCrossRef

432.

Noordam R, Aarts N, Peeters RP, Hofman A, Stricker BH, Visser LE. Selective serotonin reuptake inhibitors decrease pancreatic insulin secretion in older adults and increase the risk of insulin dependence in type 2 diabetes patients. J Clin Psychiatry. 2016;77(9):e1124–9.PubMedCrossRef

433.

Noordam R, Direk N, Sitlani CM, Aarts N, Tiemeier H, Hofman A, et al. Identifying genetic loci associated with antidepressant drug response with drug-gene interaction models in a population-based study. J Psychiatr Res. 2015;62:31–7.PubMedCrossRef

434.

Mulder M, Kiefte-de Jong JC, Goessens WH, de Visser H, Hofman A, Stricker BH, et al. Risk factors for resistance to ciprofloxacin in community-acquired urinary tract infections due to Escherichia coli in an elderly population. J Antimicrob Chemother. 2017;72(1):281–9.PubMedCrossRef

435.

Hassing RJ, Verbon A, de Visser H, Hofman A, Stricker BH. Proton pump inhibitors and gastroenteritis. Eur J Epidemiol. 2016;31(10):1057–63.PubMedCrossRefPubMedCentral

436.

Ham AC, Ziere G, Broer L, Swart KM, Enneman AW, van Dijk SC, et al. CYP2C9 Genotypes modify benzodiazepine-related fall risk: original results from three studies with meta-analysis. J Am Med Dir Assoc. 2017;18(1):88 e1–15.CrossRef

437.

Bis JC, Sitlani C, Irvin R, Avery CL, Smith AV, Sun F, et al. Drug-gene interactions of antihypertensive medications and risk of incident cardiovascular disease: a pharmacogenomics study from the CHARGE Consortium. PLoS ONE. 2015;10(10):e0140496.PubMedCrossRefPubMedCentral

438.

Mahmoudpour SH, Baranova EV, Souverein PC, Asselbergs FW, de Boer A, Maitland-van der Zee AH, et al. Determinants of angiotensin-converting enzyme inhibitor (ACEI) intolerance and angioedema in the UK clinical practice research datalink. Br J Clin Pharmacol. 2016;82(6):1647–59.PubMedCrossRef

439.

Floyd JS, Sitlani CM, Avery CL, Noordam R, Li X, Smith AV, et al. Large-scale pharmacogenomic study of sulfonylureas and the QT, JT and QRS intervals: CHARGE Pharmacogenomics Working Group. Pharmacogenomics J. 2016. doi:10.1038/tpj.2016.90.PubMedPubMedCentral

440.

Dujic T, Zhou K, Yee SW, van Leeuwen N, de Keyser CE, Javorsky M, et al. Variants in pharmacokinetic transporters and glycemic response to metformin: a metgen meta-analysis. Clin Pharmacol Ther. 2017;101(6):763–72.PubMedCrossRefPubMedCentral

441.

Zhou K, Yee SW, Seiser EL, van Leeuwen N, Tavendale R, Bennett AJ, et al. Variation in the glucose transporter gene SLC2A2 is associated with glycemic response to metformin. Nat Genet. 2016;48(9):1055–9.PubMedCrossRefPubMedCentral

442.

Postmus I, Warren HR, Trompet S, Arsenault BJ, Avery CL, Bis JC, et al. Meta-analysis of genome-wide association studies of HDL cholesterol response to statins. J Med Genet. 2016;53(12):835–45.PubMedCrossRef

443.

Egan KM, Nabors LB, Thompson ZJ, Rozmeski CM, Anic GA, Olson JJ, et al. Analgesic use and the risk of primary adult brain tumor. Eur J Epidemiol. 2016;31(9):917–25.PubMedCrossRefPubMedCentral

444.

Engeland A, Bjorge T, Klungsoyr K, Skjaerven R, Skurtveit S, Furu K. Preeclampsia in pregnancy and later use of antihypertensive drugs. Eur J Epidemiol. 2015;30(6):501–8.PubMedCrossRefPubMedCentral

445.

Li GW, Holbrook A, Jin YL, Zhang YH, Levine MAH, Mbuagbaw L, et al. Comparison of treatment effect estimates of non-vitamin K antagonist oral anticoagulants versus warfarin between observational studies using propensity score methods and randomized controlled trials. Eur J Epidemiol. 2016;31(6):541–61.PubMedCrossRef

446.

Ludvigsson JF, Lundholm C, Ortqvist AK, Almqvist C. No association between macrolide treatment in infancy and later pyloric stenosis in Sweden. Eur J Epidemiol. 2016;31(3):331–2.PubMedCrossRef

447.

Ma YS, Persuitte GM, Andrews C, Hovey KM, LaMonte MJ, Culver AL, et al. Impact of incident diabetes on atherosclerotic cardiovascular disease according to statin use history among postmenopausal women. Eur J Epidemiol. 2016;31(8):747–61.PubMedCrossRefPubMedCentral

448.

Manzoli L, Flacco ME, Boccia S, D’Andrea E, Panic N, Marzuillo C, et al. Generic versus brand-name drugs used in cardiovascular diseases. Eur J Epidemiol. 2016;31(4):351–68.PubMedCrossRef

449.

Morch LS, Lidegaard O, Keiding N, Lokkegaard E, Kjaer SK. The influence of hormone therapies on colon and rectal cancer. Eur J Epidemiol. 2016;31(5):481–9.PubMedCrossRef

450.

Olsen J. Some options in studying side effects of drugs taken during pregnancy. Eur J Epidemiol. 2015;30(11):1137–9.PubMedCrossRef

451.

Orellana C, Saevarsdottir S, Klareskog L, Karlson EW, Alfredsson L, Bengtsson C. Postmenopausal hormone therapy and the risk of rheumatoid arthritis: results from the Swedish EIRA population-based case-control study. Eur J Epidemiol. 2015;30(5):449–57.PubMedCrossRefPubMedCentral

452.

Seliger C, Meier CR, Becker C, Jick SS, Bogdahn U, Hau P, et al. Statin use and risk of glioma: population-based case-control analysis. Eur J Epidemiol. 2016;31(9):947–52.PubMedCrossRef

453.

Thorat MA, Cuzick J. Prophylactic use of aspirin: systematic review of harms and approaches to mitigation in the general population. Eur J Epidemiol. 2015;30(1):5–18.PubMedCrossRef

454.

Wemakor A, Casson K, Garne E, Bakker M, Addor MC, Arriola L, et al. Selective serotonin reuptake inhibitor antidepressant use in first trimester pregnancy and risk of specific congenital anomalies: a European register-based study. Eur J Epidemiol. 2015;30(11):1187–98.PubMedCrossRef

455.

Vernooij MW, de Groot M, Bos D. Population imaging in neuroepidemiology. Handb Clin Neurol. 2016;138:69–90.PubMedCrossRef

456.

Bunnik EM, van Bodegom L, Pinxten W, de Beaufort ID, Vernooij MW. Ethical framework for the detection, management and communication of incidental findings in imaging studies, building on an interview study of researchers’ practices and perspectives. BMC Med Ethics. 2017;18(1):10.PubMedCrossRefPubMedCentral

457.

Bunnik EM, Vernooij MW. Incidental findings in population imaging revisited. Eur J Epidemiol. 2016;31(1):1–4.PubMedCrossRefPubMedCentral

458.

Bos D, Poels MM, Adams HH, Akoudad S, Cremers LG, Zonneveld HI, et al. Prevalence, clinical management, and natural course of incidental findings on brain MR images: the population-based Rotterdam Scan Study. Radiology. 2016;281(2):507–15.PubMedCrossRef

459.

de Groot M, Ikram MA, Akoudad S, Krestin GP, Hofman A, van der Lugt A, et al. Tract-specific white matter degeneration in aging: the Rotterdam Study. Alzheimers Dement. 2015;11(3):321–30.PubMedCrossRef

460.

Cremers LG, de Groot M, Hofman A, Krestin GP, van der Lugt A, Niessen WJ, et al. Altered tract-specific white matter microstructure is related to poorer cognitive performance: the Rotterdam Study. Neurobiol Aging. 2016;39:108–17.PubMedCrossRef

461.

Sedaghat S, Cremers LG, de Groot M, Hofman A, van der Lugt A, Niessen WJ, et al. Lower microstructural integrity of brain white matter is related to higher mortality. Neurology. 2016;87(9):927–34.PubMedCrossRef

462.

Langen CD, Zonneveld HI, White T, Huizinga W, Cremers LG, de Groot M, et al. White matter lesions relate to tract-specific reductions in functional connectivity. Neurobiol Aging. 2017;51:97–103.PubMedCrossRef

463.

Akoudad S, Portegies ML, Koudstaal PJ, Hofman A, van der Lugt A, Ikram MA, et al. Cerebral microbleeds are associated with an increased risk of stroke: the Rotterdam Study. Circulation. 2015;132(6):509–16.PubMedCrossRef

464.

Akoudad S, Wolters FJ, Viswanathan A, de Bruijn RF, van der Lugt A, Hofman A, et al. Association of cerebral microbleeds with cognitive decline and dementia. JAMA Neurol. 2016;73(8):934–43.PubMedCrossRef

465.

Selwaness M, Bos D, van den Bouwhuijsen Q, Portegies ML, Ikram MA, Hofman A, et al. Carotid atherosclerotic plaque characteristics on magnetic resonance imaging relate with history of stroke and coronary heart disease. Stroke. 2016;47(6):1542–7.PubMedCrossRef

466.

Selwaness M, Hameeteman R, Van ‘t Klooster R, Van den Bouwhuijsen Q, Hofman A, Franco OH, et al. Determinants of carotid atherosclerotic plaque burden in a stroke-free population. Atherosclerosis. 2016;255:186–92.PubMedCrossRef

467.

Bos D, Shahzad R, van Walsum T, van Vliet LJ, Franco OH, Hofman A, et al. Epicardial fat volume is related to atherosclerotic calcification in multiple vessel beds. Eur Heart J Cardiovasc Imaging. 2015;16(11):1264–9.PubMedCrossRef

468.

Shahzad R, Bos D, Metz C, Rossi A, Kirisli H, van der Lugt A, et al. Automatic quantification of epicardial fat volume on non-enhanced cardiac CT scans using a multi-atlas segmentation approach. Med Phys. 2013;40(9):091910.PubMedCrossRef

469.

Wolters FJ, Bos D, Vernooij MW, Franco OH, Heart-Brain Connection collaborative research g, Hofman A, et al. Aortic valve calcification and the risk of dementia: a population-based study. J Alzheimers Dis. 2017;55(3):893–7.PubMedCrossRef

470.

Tuenter A, Selwaness M, Arias Lorza A, Schuurbiers JC, Speelman L, Cibis M, et al. High shear stress relates to intraplaque haemorrhage in asymptomatic carotid plaques. Atherosclerosis. 2016;251:348–54.PubMedCrossRef

471.

van den Bouwhuijsen QJ, Selwaness M, Tang H, Niessen WJ, Hofman A, Franco OH, et al. Change in carotid intraplaque hemorrhage in community-dwelling subjects: a follow-up study using serial MR imaging. Radiology. 2017;282(2):526–33.PubMedCrossRef

472.

Sedaghat S, Cremers LG, de Groot M, Hoorn EJ, Hofman A, van der Lugt A, et al. Kidney function and microstructural integrity of brain white matter. Neurology. 2015;85(2):154–61.PubMedCrossRef

473.

Zonneveld HI, Ikram MA, Hofman A, Niessen WJ, van der Lugt A, Krestin GP, et al. N-Terminal pro-B-type natriuretic peptide and subclinical brain damage in the general population. Radiology. 2016;07:160548.

474.

Wolff L, Bos D, Murad SD, Franco OH, Krestin GP, Hofman A, et al. Liver fat is related to cardiovascular risk factors and subclinical vascular disease: the Rotterdam Study. Eur Heart J Cardiovasc Imaging. 2016;17(12):1361–7.PubMedCrossRef

475.

Adams HH, Hilal S, Schwingenschuh P, Wittfeld K, van der Lee SJ, DeCarli C, et al. A priori collaboration in population imaging: the Uniform Neuro-Imaging of Virchow-Robin Spaces Enlargement consortium. Alzheimers Dement (Amst). 2015;1(4):513–20.

476.

Schmidt CO, Sierocinski E, Hegenscheid K, Baumeister SE, Grabe HJ, Volzke H. Impact of whole-body MRI in a general population study. Eur J Epidemiol. 2016;31(1):31–9.PubMedCrossRef

477.

Smits C, Kapteyn TS, Houtgast T. Development and validation of an automatic speech-in-noise screening test by telephone. Int J Audiol. 2004;43(1):15–28.PubMedCrossRef

478.

Weber KP, Aw ST, Todd MJ, McGarvie LA, Curthoys IS, Halmagyi GM. Head impulse test in unilateral vestibular loss: vestibulo-ocular reflex and catch-up saccades. Neurology. 2008;70(6):454–63.PubMedCrossRef

479.

Cox RM, Alexander GC. The international outcome inventory for hearing aids (IOI-HA): psychometric properties of the English version. Int J Audiol. 2002;41(1):30–5.PubMedCrossRef

480.

Newman CW, Sandridge SA, Bolek L. Development and psychometric adequacy of the screening version of the tinnitus handicap inventory. Otol Neurotol. 2008;29(3):276–81.PubMedCrossRef

481.

Homans NC, Metselaar RM, Dingemanse JG, van der Schroeff MP, Brocaar MP, Wieringa MH, et al. Prevalence of age-related hearing loss, including sex differences, in older adults in a large cohort study. Laryngoscope. 2017;127(3):725–30.PubMedCrossRef

482.

Rigters SC, Metselaar M, Wieringa MH, Baatenburg de Jong RJ, Hofman A, Goedegebure A. Contributing determinants to hearing loss in elderly men and women: results from the population-based Rotterdam Study. Audiol Neurootol. 2016;21(Suppl 1):10–5.PubMedCrossRef

483.

Koole A, Nagtegaal AP, Homans NC, Hofman A, Baatenburg de Jong RJ, Goedegebure A. Using the digits-in-noise test to estimate age-related hearing loss. Ear Hear. 2016;37(5):508–13.PubMedCrossRef

484.

Rigters SC, Bos D, Metselaar M, Roshchupkin GV, Baatenburg de Jong RJ, Ikram MA, et al. Hearing impairment is associated with smaller brain volume in aging. Front Aging Neurosci. 2017;9:2.PubMedCrossRefPubMedCentral

485.

Dal Maso L, Torelli N, Biancotto E, Di Maso M, Gini A, Franchin G, et al. Combined effect of tobacco smoking and alcohol drinking in the risk of head and neck cancers: a re-analysis of case-control studies using bi-dimensional spline models. Eur J Epidemiol. 2016;31(4):385–93.PubMedCrossRef

486.

Leoncini E, Edefonti V, Hashibe M, Parpinel M, Cadoni G, Ferraroni M, et al. Carotenoid intake and head and neck cancer: a pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Eur J Epidemiol. 2016;31(4):369–83.PubMedCrossRef

487.

Serra-Majem L. Head and neck cancer: smoking, drinking, eating andaEuro broken vertical bar sexual practices. Eur J Epidemiol. 2016;31(4):333–5.PubMedCrossRef

Springer Medizin

The Rotterdam Study: 2018 update on objectives, design and main results

Abstract

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 9/2017

Consumption of alcohol and cardiovascular disease mortality: a 16 year follow-up of 115,592 Norwegian men and women aged 40–44 years

Chronic disease research in Europe and the need for integrated population cohorts

Atrial fibrillation in immigrant groups: a cohort study of all adults 45 years of age and older in Sweden

Healthcare and disease burden among refugees in long-stay refugee camps at Lesbos, Greece

Mother’s education and offspring asthma risk in 10 European cohort studies

To see and then to act, that is the challenge